<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5760495</article-id><article-id pub-id-type="doi">10.3389/fimmu.2017.01909</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Shiyang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/477230"/></contrib><contrib contrib-type="author"><name><surname>Bostick</surname><given-names>John W.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/509427"/></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/33861"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Infectious Diseases and Immunology, College of Veterinary Medicine, University of Florida</institution>, <addr-line>Gainesville, FL</addr-line>, <country>United States</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Chemical and Biological Engineering, Northwestern University</institution>, <addr-line>Evanston, IL</addr-line>, <country>United States</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Marina Cella, Washington University in St. Louis, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: John B. Sunwoo, Stanford University, United States; Marco Colonna, Washington University in St. Louis, United States</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Liang Zhou, <email>liangzhou497@ufl.edu</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>05</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>8</volume><elocation-id>1909</elocation-id><history><date date-type="received"><day>14</day><month>9</month><year>2017</year></date><date date-type="accepted"><day>14</day><month>12</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#169; 2018 Li, Bostick and Zhou.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Li, Bostick and Zhou</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>With striking similarity to their adaptive T helper cell counterparts, innate lymphoid cells (ILCs) represent an emerging family of cell types that express signature transcription factors, including T-bet<sup>+</sup> Eomes<sup>+</sup> natural killer cells, T-bet<sup>+</sup> Eomes<sup>&#8722;</sup> group 1 ILCs, GATA3<sup>+</sup> group 2 ILCs, ROR&#947;t<sup>+</sup> group 3 ILCs, and newly identified Id3<sup>+</sup> regulatory ILC. ILCs are abundantly present in barrier tissues of the host (e.g., the lung, gut, and skin) at the interface of host&#8211;environment interactions. Active research has been conducted to elucidate molecular mechanisms underlying the development and function of ILCs. The aryl hydrocarbon receptor (Ahr) is a ligand-dependent transcription factor, best known to mediate the effects of xenobiotic environmental toxins and endogenous microbial and dietary metabolites. Here, we review recent progresses regarding Ahr function in ILCs. We focus on the Ahr-mediated cross talk between ILCs and other immune/non-immune cells in host tissues especially in the gut. We discuss the molecular mechanisms of the action of Ahr expression and activity in regulation of ILCs in immunity and inflammation, and the interaction between Ahr and other pathways/transcription factors in ILC development and function with their implication in disease.</p></abstract><kwd-group><kwd>aryl hydrocarbon receptor</kwd><kwd>innate lymphoid cell</kwd><kwd>mucosal immunity</kwd><kwd>gut</kwd><kwd>microbiota and immunity</kwd></kwd-group><counts><fig-count count="1"/><table-count count="1"/><equation-count count="0"/><ref-count count="190"/><page-count count="13"/><word-count count="12922"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Innate lymphoid cells (ILCs) are newly identified cell populations, which mirror helper T cells, such as Th1, Th2, and Th17&#8201;cells, by expressing similar transcription factors and cytokines (<xref rid="B1" ref-type="bibr">1</xref>&#8211;<xref rid="B3" ref-type="bibr">3</xref>). ILCs are divided into group 1 ILCs (ILC1) (T-bet<sup>+</sup>), group 2 ILCs (ILC2) (GATA3<sup>+</sup>), and group 3 ILCs (ILC3) (ROR&#947;t<sup>+</sup>) (<xref rid="B1" ref-type="bibr">1</xref>). To join the group, a new type of ILC that express the transcription factor Id3 and exhibit regulatory function [known as regulatory ILC (ILCreg)] have also recently been identified (<xref rid="B4" ref-type="bibr">4</xref>). Notably, natural killer (NK) cells have been defined as distinct population from ILC1, based on eomesdermin (Eomes) expression and a distinct progenitor from other ILCs (<xref rid="B5" ref-type="bibr">5</xref>). ILCs are predominantly locate at the mucosal barriers and participate in various biological processes, such as control of pathogenic infection, progression of autoimmune disease, as well as development of cancer (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). Different from adaptive immune cells, ILCs lack the antigen stimulation step and respond quickly under certain contexts of disease (<xref rid="B8" ref-type="bibr">8</xref>). The aryl hydrocarbon receptor (Ahr) is a ligand-dependent transcriptional factor, which can sense environmental and endogenous compounds generated by commensal, dietary, or cellular metabolism (<xref rid="B9" ref-type="bibr">9</xref>&#8211;<xref rid="B11" ref-type="bibr">11</xref>). Ahr has been studied in the development and/or function of various immune/non-immune cells (<xref rid="B11" ref-type="bibr">11</xref>) and recently found to be key regulator of ILC3 (<xref rid="B12" ref-type="bibr">12</xref>&#8211;<xref rid="B14" ref-type="bibr">14</xref>). There are many extensive reviews on Ahr in other immune cells. In this review, we focus our efforts on summarizing the recent progresses on decoding Ahr physiological functions in the development and function of ILCs, as well as Ahr-mediated cross talk between ILCs and other immune/non-immune cells in host tissues, especially in the gut. We discuss the molecular regulation of Ahr expression and activity in ILCs, and the interaction between Ahr and other pathways/transcription factors in ILC development and function. We also identify areas that need further study, especially the role of Ahr in group 1 and group 2 ILCs.</p></sec><sec id="S2"><title>Description and Function of ILCs</title><p>Innate lymphoid cells share the same progenitor, common lymphoid progenitors (CLPs), as adaptive immune cells, including T and B cells (<xref rid="B15" ref-type="bibr">15</xref>). CLPs differentiate toward unique direction to &#945;-lymphoid precursor, and then common helper innate lymphoid progenitor (CHILP), to become ILCs, including NK cells, ILC1, ILC2, ILC3, and ILCreg (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B16" ref-type="bibr">16</xref>). The lineage-defining transcription factors, key regulators, stimuli, and effector molecules are summarized in Table <xref ref-type="table" rid="T1">1</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Features of innate lymphoid cell (ILC) subsets.</p></caption></table-wrap><sec id="S2-1"><title>Group 1 ILC</title><p>While NK cells are predominantly circulating in the blood and secondary lymphoid organs such as the lymph nodes and spleen, NK cells are also found in some non-lymphoid tissues such as the liver, uterus, and lung (<xref rid="B17" ref-type="bibr">17</xref>). Closely related in function to NK cells, ILC1 are present in various non-lymphoid tissues, including intestine, liver, salivary glands, and the female reproductive tract (<xref rid="B18" ref-type="bibr">18</xref>). The development and function of ILC1 depend on T-bet, while the requirement of T-bet by NK cells appears to be complicated since deletion of T-bet reduces the numbers of NK cells in liver, spleen, and peripheral blood (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>), but not in bone marrow and intestine (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>). The transcription factor, Eomes, distinguishes NK cells from ILC1 and is indispensable for the development of NK cells (<xref rid="B5" ref-type="bibr">5</xref>). Recent studies indicate that NK cells and ILC1 derive from different progenitors, which further separate NK cells from ILC1 (<xref rid="B5" ref-type="bibr">5</xref>). Although developmentally identified as two distinct populations, NK cells and ILC1 can be stimulated by IL-12, IL-15, or IL-18 to produce interferon &#947; (IFN&#947;) and tumor necrosis factor (TNF) (<xref rid="B18" ref-type="bibr">18</xref>), which are critical for the immune response to control intracellular pathogens, viruses, and tumors (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). NK cells have the ability to secrete granzyme and perforin to promote cytotoxic function, which imparts NK cells tumor suppression activity, distinct from ILC1 (<xref rid="B23" ref-type="bibr">23</xref>). Different from intestinal lamina proprial ILC1 that express T-bet but not Eomes, intraepithelial ILC1 have been shown to express both T-bet and Eomes, and produce granzyme and perforin; however, lack of the requirement of IL-15 signals for their maintenance distinguishes intraepithelial ILC1 from NK cells (<xref rid="B24" ref-type="bibr">24</xref>).</p></sec><sec id="S2-2"><title>Group 2 ILC</title><p>Group 2 ILCs have been identified to localize in various lymphoid/non-lymphoid tissues, including intestine, lung, adipose tissue, spleen, nasal tissue, and skin, while immature ILC2 are also reported in bone marrow (<xref rid="B25" ref-type="bibr">25</xref>&#8211;<xref rid="B27" ref-type="bibr">27</xref>). The development and function of ILC2 require GATA3, ROR&#945;, Gfi1, TCF1, Bcl11b, and Notch signaling, of which GATA3 acts as the defining marker of ILC2 (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B28" ref-type="bibr">28</xref>&#8211;<xref rid="B34" ref-type="bibr">34</xref>). Upon stimulation with IL-25, IL-33, or thymic stromal lymphopoietin (TSLP), ILC2 can produce IL-5, IL-13, and IL-4, similar to Th2 cells, which contribute to the control of helminth infection and pathology of allergic inflammation (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B35" ref-type="bibr">35</xref>&#8211;<xref rid="B39" ref-type="bibr">39</xref>). ILC2 can also express IL-9 to promote the epithelial cell maintenance in the lung (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Amphiregulin is an effector molecule produced by ILC2 to participate in the tissue repair in the gut (<xref rid="B42" ref-type="bibr">42</xref>). Additionally, ILC2 have been shown to promote the beiging of white adipose tissue to control obesity through the production of methionine-enkephalin peptides (<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>).</p></sec><sec id="S2-3"><title>Group 3 ILC</title><p>Group 3 ILCs are mainly found in gastrointestinal tract, while few ILC3 are present in other tissues (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B46" ref-type="bibr">46</xref>). ILC3 are heterogeneous, and can be divided, based on the expression of the natural cytotoxicity receptor (NCR or NKp46/NKp44) and chemokine receptor 6 (CCR6), into three major groups: NCR<sup>+</sup>CCR6<sup>&#8722;</sup> ILC3, NCR<sup>&#8722;</sup>CCR6<sup>+</sup> ILC3, and NCR<sup>&#8722;</sup>CCR6<sup>&#8722;</sup> ILC3 (<xref rid="B47" ref-type="bibr">47</xref>). It should be noted that the above discussion is on ILC3 after birth. Fetal ILC3, also known as lymphoid tissue inducer (LTi) cells, which express ROR&#947;t, function in the formation of secondary lymphoid organs, such as lymph nodes and gut-associated lymphoid tissue (<xref rid="B48" ref-type="bibr">48</xref>&#8211;<xref rid="B50" ref-type="bibr">50</xref>). Postnatal CCR6<sup>+</sup> ILC3 found in the gut and other lymphoid organs are known as LTi-like cells (<xref rid="B51" ref-type="bibr">51</xref>). While ROR&#947;t is the common transcription factor that is required for the development, maintenance, and function of all ILC3 (<xref rid="B52" ref-type="bibr">52</xref>), NCR<sup>+</sup> ILC3 also appear to depend on T-bet for development and function (<xref rid="B53" ref-type="bibr">53</xref>). When stimulated, all three subsets of ILC3 produce IL-22, while NCR<sup>+</sup> ILC3, relying on T-bet, can express IFN&#947; (<xref rid="B53" ref-type="bibr">53</xref>). In addition, ILC3 can also secret IL-17A and GM-CSF (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B54" ref-type="bibr">54</xref>). GATA3 is required for development of all IL-7R&#945;-expressing ILCs (<xref rid="B55" ref-type="bibr">55</xref>). Although GATA3 expression is high in ILC2, it is also expressed at a lower level in ILC1 and ILC3 and required for their maintenance (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B56" ref-type="bibr">56</xref>). It has been shown that GATA3 is important for ILC3 function to produce IL-22 (<xref rid="B47" ref-type="bibr">47</xref>). ILC3 are involved in clearance of bacterial and fungal infection, control of enteric virus infection, and maintenance of microbiota (<xref rid="B57" ref-type="bibr">57</xref>&#8211;<xref rid="B62" ref-type="bibr">62</xref>), while recent studies suggest that GM-CSF, as well as IL-22, expressed by ILC3 participate in ILC-driven colitis (<xref rid="B63" ref-type="bibr">63</xref>&#8211;<xref rid="B65" ref-type="bibr">65</xref>). After birth, ILC3 are also required for the development of cryptopatches and isolated lymphoid follicles (ILFs) in the gut through expression of lymphotoxin and CCR6 (<xref rid="B66" ref-type="bibr">66</xref>&#8211;<xref rid="B69" ref-type="bibr">69</xref>).</p></sec><sec id="S2-4"><title>Regulatory ILC</title><p>In addition to ILCs discussed above, a new ILC subset, with the ability to suppress ILC1 and ILC3 to promote the resolution of intestinal inflammation, has been identified recently in mice (<xref rid="B4" ref-type="bibr">4</xref>). Although further work is needed to confirm the existence and function of this cell type, ILCreg, mainly populate in the gut, develop from CHILP in bone marrow, and require transcription factor Id3 for their development. The regulatory function of ILCreg is mediated by IL-10. TGF&#946;1 is required for the expansion of ILCreg during inflammation (<xref rid="B4" ref-type="bibr">4</xref>). In human, the regulatory ILC (ILCreg) are also reported in the context of cancer recently (<xref rid="B70" ref-type="bibr">70</xref>), to suppress the expansion of tumor-associated T cells. Different from the mouse ILCreg that do not express other ILC signature transcription factors, the human ILCreg, present in the tumor tissue, express high levels of Eomes, T-bet, GATA3, ROR&#945;, and Ahr, suggesting an overlapping transcriptional profile of the human ILCreg and other ILC subsets.</p></sec></sec><sec id="S3"><title>Ahr Structure and Activation</title><p>Aryl hydrocarbon receptor is a ligand-dependent transcription factor and belongs to Per-Arnt-Sim (PAS) superfamily (<xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B72" ref-type="bibr">72</xref>). Various Ahr ligands have been identified, including environmental pollutants such as dioxins, and multiple physiologic ligands generated by microbiota, diet, and host metabolism (<xref rid="B73" ref-type="bibr">73</xref>&#8211;<xref rid="B76" ref-type="bibr">76</xref>). Without ligand binding, Ahr localizes in the cytoplasm, and this inactive status is maintained by interacting with 90-kDa heat shock protein (HSP90) (<xref rid="B77" ref-type="bibr">77</xref>). Ahr also interacts with Ahr-interacting protein (AIP) which protects Ahr from degradation (<xref rid="B78" ref-type="bibr">78</xref>), as well as p23 (<xref rid="B79" ref-type="bibr">79</xref>). Upon ligand activation, the conformation of Ahr is changed, leading to the release of Ahr from the protein complex and the translocation of Ahr into the nucleus, where Ahr interacts with Ahr nuclear translocator (ARNT) through PAS-A domain and bHLH domain (<xref rid="B80" ref-type="bibr">80</xref>) and acts as a transcription factor targeting dioxin response element (DRE)-containing genes, which are prototypically cytochrome P450 family, like Cyp1a1, but also include genes involved in other important biological processes (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B81" ref-type="bibr">81</xref>). Several partners of Ahr have been identified, such as ROR&#947;t, sterol regulatory element binding transcription factor 1, LXR, NF-&#954;B (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B83" ref-type="bibr">83</xref>). The involvement of ARNT in these reported interactions remains to be determined.</p><p>Aryl hydrocarbon receptor was initially identified as the sensor for 2,3,7,8-tetracholrodibenzo-p-dioxin (TCDD) (<xref rid="B84" ref-type="bibr">84</xref>). Later, a variety of Ahr ligands were identified from different physiological sources, such as tryptophan (Trp) metabolism and microbiota. The metabolism of Trp generates Ahr ligands through catalysis by indoleamine-2,3-dioxygenase (IDO) and tryptophan-2,3-dioxygenase (TDO) to kynurenine (Kyn), which acts as an Ahr ligand (<xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B85" ref-type="bibr">85</xref>, <xref rid="B86" ref-type="bibr">86</xref>). Independent of IDO/TDO, Trp can also be metabolized by the tryptamine and serotonin pathway, of which the metabolites can act as Ahr agonist (<xref rid="B87" ref-type="bibr">87</xref>, <xref rid="B88" ref-type="bibr">88</xref>). Notably, Trp can be photo-oxidized by ultraviolet light or metabolized by other pathways to 6-formylindolo[3,2-b]carbazole (FICZ), which has been proven as a physiologically relevant Ahr agonist (<xref rid="B89" ref-type="bibr">89</xref>, <xref rid="B90" ref-type="bibr">90</xref>). Of note, a higher concentration of Kyn, at micromolar concentration, compared to nanomolar of TCDD or FICZ, is required for Ahr activation.</p><p>In addition to cellular metabolism, commensal bacteria can catalyze Trp into Ahr ligands as well (<xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B91" ref-type="bibr">91</xref>). Lactobacilli expand when the energy source switches from sugar to Trp, and produce indole-3-aldehyde which acts as Ahr ligand to promote IL-22 production by ILC3 (<xref rid="B74" ref-type="bibr">74</xref>). Consequently, the Ahr-IL-22 axis provides resistance to the fungus <italic>Candida albicans</italic> and protection from dextran sulfate sodium (DSS)-induced colitis. In accordance with the importance of Trp in mice, recent research suggests that dysregulation of commensal bacteria that use Trp to generate Ahr ligands may correlate with the pathogenesis of human inflammatory bowel disease (IBD) (<xref rid="B92" ref-type="bibr">92</xref>). Besides the Ahr ligands generated by cellular metabolism or commensal bacteria, bacterial pigment factors such as the phenazines from <italic>Pseudomonas aeruginosa</italic> and the naphthoquinone phthiocol from <italic>Mycobacterium tuberculosis</italic> can also act as ligands for Ahr, and contribute to the antibacterial response through activation of the Ahr pathway (<xref rid="B93" ref-type="bibr">93</xref>).</p></sec><sec id="S4"><title>Ahr Expression in ILCs</title><p>Aryl hydrocarbon receptor is thought to be expressed ubiquitously in various organs and cell types, including immune cells, such as Th17&#8201;cells, IL-17-producing &#947;&#948; T cells, Treg cells, CD8&#945;&#945; IEL lymphocytes, B cells, Langerhans cells, monocytes, and splenic dendritic cells (DCs) (<xref rid="B94" ref-type="bibr">94</xref>&#8211;<xref rid="B100" ref-type="bibr">100</xref>). However, the expression of Ahr in ILCs, at both mRNA and protein level, remains to be clarified. Genome-wide transcription analysis of different ILC populations, which is available at IMMGEN.ORG, has shown that <italic>Ahr</italic> mRNA is detectable among ILCs (<xref rid="B101" ref-type="bibr">101</xref>). It has been reported that cytokine stimulation, including IL-2, IL-12, or IL-15, can enhance Ahr expression in splenic NK cells (<xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B103" ref-type="bibr">103</xref>). In addition, the transcription factor, Distal-Less Homeobox 3 is found to enhance Ahr transcription in NK cells, while its function remains to be determined (<xref rid="B104" ref-type="bibr">104</xref>).</p><p>We and other groups have reported the expression of Ahr in ILC3. Differential levels of Ahr were observed in different subsets of ILC3 (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B41" ref-type="bibr">41</xref>). NCR<sup>+</sup> ILC3 express higher Ahr than the other two subsets of ILC3, which lack NCR on the surface (<xref rid="B13" ref-type="bibr">13</xref>). How Ahr expression is regulated in ILCs has been a subject of active research. Recent study has shown that in NCR<sup>+</sup> ILC3, Wiskott-Aldrich syndrome protein and SCAR homolog (WASH) activates Ahr expression by recruiting AT-Rich Interaction Domain 1A (Arid1a) to the <italic>Ahr</italic> promoter, and thus maintains NCR<sup>+</sup> ILC3 in the gut (<xref rid="B105" ref-type="bibr">105</xref>).</p><p>Although further investigation on Ahr expression, especially at the protein level, needs to be conducted, the public data at IMMGEN.ORG appears to show that the special microenvironment of the gut correlates with the high Ahr transcriptional expression, since lower Ahr expression is observed in spleen or liver NK cells or ILC1. In a <italic>Cyp1a1</italic> (a target gene of Ahr) reporter mouse, Ahr was shown mainly active in the gut in homeostatic conditions (<xref rid="B106" ref-type="bibr">106</xref>). A recent paper using a mouse model in which GFP was knocked into the endogenous locus of Ahr showed that among Tregs in various tissues, gut Treg cells express the highest amounts of Ahr, suggesting a tissue adaptation of Ahr expression (<xref rid="B107" ref-type="bibr">107</xref>). Identification of the gut specific factors, such as cytokines/metabolites and transcription factors that facilitate Ahr expression will provide insights into the regulation of Ahr expression in ILCs, and potentially be translated into clinical manipulation of the Ahr pathway. To get a molecular understanding on the regulation of Ahr expression, it is of importance to analyze chromatin status of the Ahr locus and Ahr interactions with key transcription factors in different ILC populations.</p></sec><sec id="S5"><title>Involvement of Ahr in ILC Function and Regulation</title><sec id="S5-1"><title>Ahr and NK Cells/ILC1</title><p>In tumor, Ahr promotes NK cell cytotoxicity and its production of IFN&#947; (<xref rid="B103" ref-type="bibr">103</xref>). During <italic>T. gondii</italic> infection, Ahr is also required for maximal IL-10 production by NK cells (<xref rid="B102" ref-type="bibr">102</xref>). It has also been shown that Ahr maintains liver-resident CD49a<sup>+</sup> cells by regulating cytokine-induced cell death (<xref rid="B108" ref-type="bibr">108</xref>). Notably, CD49a is considered as a marker for ILC1 in the liver, instead of NK cells (<xref rid="B18" ref-type="bibr">18</xref>). Therefore, these data may suggest that Ahr is required for liver ILC1 maintenance (<xref rid="B108" ref-type="bibr">108</xref>).</p><p>So far, the studies on Ahr in NK cells or ILC1 have been predominantly focused in the liver or spleen. The function of Ahr in the gut ILC1 and NK cells still remains to be elucidated, given that the gastrointestinal tract is another site for these two cell populations, especially for ILC1 (<xref rid="B5" ref-type="bibr">5</xref>).</p></sec><sec id="S5-2"><title>Ahr and ILC2</title><p>Currently, limited knowledge is available on the function of Ahr in ILC2. IFN&#947; has recently been shown to inhibit ILC2 activation (<xref rid="B109" ref-type="bibr">109</xref>, <xref rid="B110" ref-type="bibr">110</xref>). In addition, IFN&#947; can induce <italic>Ido1</italic> mRNA and Ido protein expression in some cell types (<xref rid="B111" ref-type="bibr">111</xref>, <xref rid="B112" ref-type="bibr">112</xref>). Given that Ido1 is able to catalyze Trp to Kyn, which acts as a ligand for Ahr, it is tempting to speculate that Ahr ligands, such as Kyn, might suppress ILC2 function but additional works are needed to test this hypothesis. TNF-like ligand 1A (TL1A) has been shown to promote expansion and function of ILC2 in the gut (<xref rid="B113" ref-type="bibr">113</xref>). RNA-seq data reveal that TL1A enhances Ahr expression in the presence of IL-33 and IL-25 in human ILC2 (<xref rid="B114" ref-type="bibr">114</xref>). Thus, the function of Ahr in ILC2 and in <italic>in vivo</italic> models of ILC2-driven pathology remains to be investigated.</p></sec><sec id="S5-3"><title>Ahr and ILC3</title><p>Aryl hydrocarbon receptor has been relatively well studied in gut ILC3. Although it is dispensable for fetal LTi development, Ahr is essential for the maintenance and IL-22 production of ILC3 (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B45" ref-type="bibr">45</xref>). Although the precise mechanisms by which Ahr regulates the homeostasis of ILC3 still remain to be determined, it has been described that Ahr can regulate survival and/or proliferation of ILC3 (Figure <xref ref-type="fig" rid="F1">1</xref>). First, it is reported that Ahr is important for the survival of ILC3 by promoting the expression of anti-apoptotic proteins, such as Bcl-2. Ahr upregulates IL-7 receptor (IL-7R) in ILC3, in line with the role of IL-7/IL-7R signaling pathway in the supporting the survival of ILC3 (<xref rid="B13" ref-type="bibr">13</xref>). Second, it has been shown that Ahr-deficient ILC3 have reduced Ki67 expression, indicating that decreased proliferation may lead to the defective expansion of ILC3. Furthermore, Ahr can regulate the expression of Kit through binding to DRE at the promoter of <italic>Kit</italic> locus, suggesting direct regulation of Kit expression by Ahr at the transcriptional level (<xref rid="B12" ref-type="bibr">12</xref>). Finally, Ahr supports the development of ILC3 presumably through promoting the transcription of Notch 1 and Notch 2, although defects in Notch signaling have more effect on NCR-expressing ILC3 than NCR-negative ILC3 (<xref rid="B45" ref-type="bibr">45</xref>). By regulating the maintenance and function of ILC3, Ahr is critical for the clearance of <italic>Citrobacter rodentium</italic>, a murine pathogen that models human enterohemorrhagic <italic>Escherichia coli</italic> and enteropathogenic <italic>E. coli</italic> infections in the gut (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B64" ref-type="bibr">64</xref>), as well as for the pathology of anti-CD40-incuced colitis (<xref rid="B64" ref-type="bibr">64</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Aryl hydrocarbon receptor (Ahr)-mediated cross talk between innate lymphoid cells (ILCs) and immune/non-immune cells. Ahr ligands derived from the diet or microbiota activate Ahr to promote group 3 ILCs (ILC3) homeostasis by enhancing the survival or proliferation of ILC3. MHC-II<sup>+</sup> ILC3, which are mainly CCR6<sup>+</sup>, suppress pathogenic Th17 response to commensal bacteria, while T-bet<sup>+</sup> ILC3, together with group 1 ILC (ILC1), promote Th17&#8201;cells. Both Th17&#8201;cells and ILC3 can produce IL-22 to control commensal/pathogenic bacteria through facilitating the production of antimicrobial peptides by epithelial cells. Ahr ligand could potentially regulate natural killer (NK) cells, ILC1, and group 2 ILCs (ILC2) through the Ahr pathway in the gut. NK cells and ILC1 can help the host to clear pathogens, like <italic>Salmonella typhimurium</italic>, by production of effector cytokine IFN&#947;. ILC2, through expression of MHC class II (MHC-II) and programmed death ligand 1 (PD-L1), enhance Th2 cells. ILC2 and Th2 cells protect the host from helminth infection by secreting type 2 cytokines, including IL-5, IL-13, and IL-4. Ahr ligand enhances Cyp1a1 expression in gut epithelial cells, and as a feedback negative control loop, Cyp1a1 degrades Ahr ligand to prevent overt Ahr-mediated immune responses. Solid lines and arrows depict known regulation. Dotted lines and arrows depict to-be-determined regulation in the gut.</p></caption><graphic xlink:href="fimmu-08-01909-g001"/></fig></sec><sec id="S5-4"><title>Ahr in ILC Plasticity</title><p>The plasticity of ILCs has been observed in both human and mouse systems under steady state or certain disease models, while the mechanism that drives the plasticity of ILCs is still not well understood. The conversion of ILC3 to ILC1 is characterized by the loss of ROR&#947;t and gain of T-bet expression to become exILC3 (<xref rid="B115" ref-type="bibr">115</xref>, <xref rid="B116" ref-type="bibr">116</xref>). These exILC3 stop the production of IL-22, and begin to secrete IFN&#947;. IL-15 and IL-12 can lead to downregulation of ROR&#947;t, and enhance IFN&#947; expression (<xref rid="B116" ref-type="bibr">116</xref>). In support, IL-12 has been shown to participate in the transition of ILC3 to ILC1 in humans (<xref rid="B115" ref-type="bibr">115</xref>, <xref rid="B117" ref-type="bibr">117</xref>). There is an increase of ILC1 and decrease in ILC3 in the intestines of patients with Crohn&#8217;s disease, suggesting the ILC3-derived ILC1 might contribute to the pathology of human IBD (<xref rid="B115" ref-type="bibr">115</xref>, <xref rid="B117" ref-type="bibr">117</xref>). Human ILC1 can also convert to ILC3 in the presence of IL-2, IL-23, and IL-1&#946;, and retinoic acid can accelerate this process which may depend on the receptors for retinoic acid (<xref rid="B117" ref-type="bibr">117</xref>). Although Ahr has been shown to prevent the differentiation of human ILC3 to NK cells (<xref rid="B118" ref-type="bibr">118</xref>), it is of interest to determine whether Ahr participates in the transition of ILC3 to ILC1. Of note, microbiota has been shown to maintain the ROR&#947;t expression by ILC3 through IL-7 signaling in the gut (<xref rid="B116" ref-type="bibr">116</xref>). Since commensal bacteria have the ability to produce Ahr ligands, Ahr might receive the signals from microbiota to maintain ILC3 through upregulating IL-7R.</p><p>The plasticity of ILC2 has recently been reported (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B119" ref-type="bibr">119</xref>&#8211;<xref rid="B121" ref-type="bibr">121</xref>). Gfi1, a key transcription factor for ILC2 development and function, appears to sustain ILC2, as deletion of Gfi1 in ILC2 leads to upregulation of ROR&#947;t and IL-17 production by these ILC2 (<xref rid="B29" ref-type="bibr">29</xref>). Similarly, Bcl11b, a recently defined transcription factor for ILC2, maintains the stability of ILC2 by suppressing ROR&#947;t and Ahr expression (<xref rid="B31" ref-type="bibr">31</xref>). ILC2 were found to convert to IFN&#947;-producing ILC1 in the lung by IL-12 and IL-18 (<xref rid="B119" ref-type="bibr">119</xref>&#8211;<xref rid="B121" ref-type="bibr">121</xref>). The conversion is dependent on T-bet expression, and enhanced by IL-1&#946; through induction of the IL-12 receptor alpha (Il12r&#945;). As the frequency of ILC1 shows positive correlation with disease severity in patients with chronic obstructive pulmonary disease or chronic rhinosinusitis with nasal polyps (<xref rid="B119" ref-type="bibr">119</xref>, <xref rid="B121" ref-type="bibr">121</xref>), the plasticity of ILC2 could be a therapeutic target for these respiratory diseases. Whether Ahr plays any role in ILC2 conversion to ILC1 needs to be established.</p></sec></sec><sec id="S6"><title>Ahr-Mediated Modulation of the Cross Talk Between ILCs and Other Cells</title><sec id="S6-1"><title>Cross Talk with Innate Immune Cells</title><p>Innate immune cells, such as dendritic cells (DCs) and mononuclear phagocytes (MNPs), have been shown to interact with ILCs. Both CX3CR1<sup>+</sup> MNPs and CD103<sup>+</sup> DCs can induce IL-22 production by ILC3, while CX3CR1<sup>+</sup> MNPs can also recruit ILC3 to the gut through CXCL16&#8211;CXCR6 pathway (<xref rid="B122" ref-type="bibr">122</xref>&#8211;<xref rid="B124" ref-type="bibr">124</xref>). Ahr controls the differentiation and function of DCs by arresting the differentiation of progenitors, as well as regulating antigen presentation in DCs (<xref rid="B125" ref-type="bibr">125</xref>&#8211;<xref rid="B128" ref-type="bibr">128</xref>). In addition, recent work has shown that Ahr controls differentiation of monocyte to monocyte-derived macrophages in the human system (<xref rid="B129" ref-type="bibr">129</xref>). Thus, it is possible that Ahr controls ILC3 through regulating these innate immune cells. On the other hand, innate immune cells can be attracted by ILC-secreted cytokines. IL-5 and IL-13, produced by ILC2, can recruit eosinophils which are essential for the clearance of helminth infections (<xref rid="B25" ref-type="bibr">25</xref>). ILC3 can secrete IL-17A, which is proved to attract neutrophils into the intestine (<xref rid="B130" ref-type="bibr">130</xref>, <xref rid="B131" ref-type="bibr">131</xref>). Thus, lack of ILC3 in Ahr-deficient mice may account for the resistance of anti-CD40 colitis (<xref rid="B64" ref-type="bibr">64</xref>).</p></sec><sec id="S6-2"><title>Cross Talk with Adaptive Immune Cells</title><p>The absence of Ahr in ILC3 leads to defects in the IL-22-producing ability of ILC3. The impaired IL-22 production in the gut of Ahr-deficient mice causes a decrease in antimicrobial peptide production by gut epithelial cells (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B132" ref-type="bibr">132</xref>), leading to increased segmented filamentous bacteria (SFB) which has been established to induce Th17&#8201;cells in the gut (<xref rid="B133" ref-type="bibr">133</xref>, <xref rid="B134" ref-type="bibr">134</xref>). However, recent papers also show that SFB induced IL-22 production by ILC3 can induce epithelial production of Serum Amyloid A, which in turn promotes Th17&#8201;cells (<xref rid="B135" ref-type="bibr">135</xref>, <xref rid="B136" ref-type="bibr">136</xref>). Thus, the role of ILC3-derived IL-22 in regulating Th17&#8201;cells will require further investigation into the underlying molecular mechanisms, which are most likely indirect given the lack of expression IL-22R by immune cells. By supporting ILC3 homeostasis, Ahr controls cryptopatches formation, and consequently the genesis of ILFs in the gut (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B137" ref-type="bibr">137</xref>). As ILFs have been recognized as a site for the production of intestinal IgA responses (<xref rid="B138" ref-type="bibr">138</xref>), it is possible that Ahr contributes to B cell responses <italic>via</italic> the regulation of ILC3, in addition to its B cell-intrinsic roles (<xref rid="B96" ref-type="bibr">96</xref>, <xref rid="B97" ref-type="bibr">97</xref>, <xref rid="B139" ref-type="bibr">139</xref>).</p><p>Recent research showed that ILC2 are critical for memory Th2 cell responses, as impaired Th2 cells are found in sensitized mice, which lack ILC2 (<xref rid="B140" ref-type="bibr">140</xref>). During helminth infection, ILC2 have been shown to express the checkpoint molecule Programmed Death Ligand 1, through which ILC2 support Th2 polarization, and effective Th2 dependent-anti-helminth response (<xref rid="B141" ref-type="bibr">141</xref>). Additionally, ILC2, through producing IL-9, can sustain the proliferation of ILC2 and activation of Treg cells in arthritis, by which promote the resolution of inflammation (<xref rid="B142" ref-type="bibr">142</xref>). It is of interest to note that, with the resistance to IL-7-induced downregulation of IL-7R, ILCs limit the availability of IL-7 for T cells, thus controlling the homeostasis of T cells (<xref rid="B143" ref-type="bibr">143</xref>). Given that Ahr deficiency leads to reduction of ILC3, it remains to be determined whether enhanced T cell proliferation and Th17&#8201;cell differentiation observed in Ahr knockout mice are caused by increased IL-7 that is made available to T cells.</p><p>In addition to the cross talk between ILCs and adaptive immune cells through cytokines, ILCs interact with T cells through the expression of MHC class II (MHC-II) molecules on the surface. The MHC-II-mediated interaction between ILCs and T cells controls the activation or anergy of T cells (Figure <xref ref-type="fig" rid="F1">1</xref>). For example, ILC2, <italic>via</italic> MHC-II and co-stimulatory molecules, CD80 and CD86, interact with and activate T cells (<xref rid="B144" ref-type="bibr">144</xref>). Different from ILC2, ILC3 expressing MHC-II but not the co-stimulatory molecules CD80 and CD86, induce T cell apoptosis and tolerance in the gut (<xref rid="B145" ref-type="bibr">145</xref>, <xref rid="B146" ref-type="bibr">146</xref>). However, ILC3 express CD30 ligand and OX40 ligand, which may contribute to the maintenance of CD4<sup>+</sup> T cell memory (<xref rid="B147" ref-type="bibr">147</xref>). Although there is no direct evidence indicating whether Ahr regulates MHC-II or co-stimulatory molecule expression by ILC2 and ILC3, Ahr may mediate the cross talk between ILCs and T cells, at least through regulating ILC numbers (Figure <xref ref-type="fig" rid="F1">1</xref>). A recent study reveals that NCR-expressing ILCs, including ILC1 and NCR<sup>+</sup> ILC3, support Th17&#8201;cells in inflamed central nervous system (<xref rid="B148" ref-type="bibr">148</xref>), which raises intriguing questions that whether similar event is evident in the gut, and how the host keeps the balance between the induction of Th17&#8201;cells by NCR<sup>+</sup> ILCs, and the inhibition of Th17&#8201;cells by CCR6<sup>+</sup> ILC3 through MHC-II expression (Figure <xref ref-type="fig" rid="F1">1</xref>).</p></sec><sec id="S6-3"><title>Cross Talk with Epithelial Cells</title><p>The cross talk between gut epithelial cells and ILC3 has been recently investigated. Over-expression of Cyp1a1, a target gene of Ahr, in epithelial cells consumes Ahr ligands in the gut, which consequently leads to the decrease of gut ILC3 (<xref rid="B106" ref-type="bibr">106</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>). These findings raise the possibility that activation of Ahr may not only promote gut ILC3 in a cell-intrinsic manner, but also maintain the ILC3 at a physiological level through controlling the availability of Ahr ligands in the gut. On the other hand, ILC3, <italic>via</italic> expression of IL-22 and lymphotoxin, regulate the fucosylation of epithelial cells which is critical for the host to control <italic>Salmonella typhimurium</italic> infection (<xref rid="B149" ref-type="bibr">149</xref>). In addition, ILC3, <italic>via</italic> producing IL-22, promote the expansion of intestinal stem cell, and consequently promote the regeneration of intestinal epithelium after gut injury (<xref rid="B150" ref-type="bibr">150</xref>, <xref rid="B151" ref-type="bibr">151</xref>).</p></sec><sec id="S6-4"><title>Cross Talk with Commensals</title><p>Aryl hydrocarbon receptor appears to mediate the interaction of ILC3 and microbiota. The absence of caspase recruitment domain family member 9 (CARD9) results in alteration of microbiota, and the altered microbiota fail to metabolize Trp into Ahr ligands, leading to decreased ILC3 and IL-22 production, and increased susceptibility of the host to colitis (<xref rid="B92" ref-type="bibr">92</xref>). Accordingly, Ahr ligands are found decreased in the microbiota of IBD patients, especially in the individuals with IBD-associated single-nucleotide polymorphism within <italic>CARD9</italic> (rs10781499), suggesting microbiota&#8211;Ahr ligand axis may be a therapeutic target of colitis in humans (<xref rid="B92" ref-type="bibr">92</xref>). Although the cross talk between ILCs and microbiota remains to be further explored, genome-wide analysis at the transcriptional level of ILCs has been conducted using RNA-seq by comparing specific pathogen-free mice to those with microbiota depletion (<xref rid="B152" ref-type="bibr">152</xref>). Marked numbers of transcripts change significantly in all ILCs upon antibiotics treatment, but the expression profile is generally maintained. Intriguingly, depletion of microbiota shows more effects on the gene expression of ILC1 and ILC2 than that of ILC3. Given the important role of Ahr in ILC3 and Ahr could sense ligands generated by commensals, for example, <italic>Lactobacillus reuteri</italic> (<xref rid="B74" ref-type="bibr">74</xref>, <xref rid="B91" ref-type="bibr">91</xref>), these findings may suggest ligands from other sources (e.g., diet) could activate the Ahr pathway in the absence of microbiota.</p></sec><sec id="S6-5"><title>Regulation of ILCs by ILCreg</title><p>With the minimal Ahr expression in mouse ILCreg at least under the steady state (<xref rid="B4" ref-type="bibr">4</xref>), it remains to be determined whether Ahr plays a role in ILCreg. In contrast to the mouse ILCreg, human ILCreg in cancer that suppress T cell expansion appear to express high level of Ahr, indicating potential role of Ahr in this population (<xref rid="B70" ref-type="bibr">70</xref>). The mouse ILCreg have been shown to regulate ILC1 and ILC3 (<xref rid="B4" ref-type="bibr">4</xref>), it is unclear whether ILCreg can suppress ILC2.</p></sec><sec id="S6-6"><title>ILC-Nervous System Interaction</title><p>The nervous system has been shown to affect ILCs. Glial cells in the gut, through secreting neurotrophic factors that bind to the neuroregulatory receptor rearranged during transfection (RET) on ILC3, promote the expression of IL-22, and consequently decrease the susceptibility to intestinal inflammation and infection (<xref rid="B153" ref-type="bibr">153</xref>). Recent studies demonstrate that among various hematopoietic cells, ILC2 uniquely express the neuropeptide neuromedin U (NMU) receptor 1 (NMUR1), which makes them respond to NMU (<xref rid="B154" ref-type="bibr">154</xref>&#8211;<xref rid="B156" ref-type="bibr">156</xref>). The activation of ILC2 by NMU leads to enhanced cell expansion and type 2 cytokine production, which promote the clearance of helminth in the gut. It remains to be determined that whether Ahr modulates ILC responses to neuromediators.</p></sec><sec id="S6-7"><title>Cooperation of Ahr and Partners in Regulating ILCs</title><p>Aryl hydrocarbon receptor has been studied for decades, and some interacting proteins, like HSP90 and AIP, have been well documented. However, only a few partners of Ahr have been functionally implicated in ILCs. In Th17 and IL-17-producing &#947;&#948; T cells, Ahr regulates IL-22 expression while the molecular mechanism of action of Ahr is unclear (<xref rid="B94" ref-type="bibr">94</xref>, <xref rid="B95" ref-type="bibr">95</xref>). However, Ahr has been shown to interact with ROR&#947;t in an overexpression system to promote IL-22 expression (<xref rid="B13" ref-type="bibr">13</xref>). ROR&#947;t is required for the recruitment of Ahr to the <italic>Il22</italic> locus, as Ahr alone fails to bind to the <italic>Il22</italic> locus. In contrast to the <italic>Il22</italic> locus, Ahr is recruited to the <italic>Cyp1a1</italic> locus independent of ROR&#947;t. These data raise a question regarding how Ahr, by cooperating with other transcription factors (e.g., ROR&#947;t), regulates gene expression in ILC3 and other lymphocytes (e.g., Th17 and &#947;&#948; T cells). In addition to ROR&#947;t, the C2H2 zinc finger transcription factor Ikaros, a key regulator of hematopoiesis, is a binding protein of Ahr in ILC3 (<xref rid="B157" ref-type="bibr">157</xref>). Ikaros negatively regulates ILC3 through zinc finger 4-dependent inhibition of transcriptional activity of the Ahr by disruption of the Ahr&#8211;ARNT complex. It will be of interest to investigate whether Ikaros participates in a complex of Ahr and ROR&#947;t to regulate ROR&#947;t activity in ILC3 development and/or function. Intriguingly, Ikaros but not Ahr is required for fetal LTi cell development, demonstrating the distinct transcriptional regulation of fetal and postnatal ILC3.</p><p>As ILC3 resemble Th17&#8201;cells in regards to key transcription factor and cytokines, knowledge of the function of Ahr in Th17&#8201;cells might be adopted into ILC3 potentially. Transcription factor Musculoaponeurotic Fibrosarcoma (MAF) has been shown to be induced by TGF&#946; in Th17&#8201;cells to promote IL-17 production and suppress IL-22 secretion (<xref rid="B158" ref-type="bibr">158</xref>). Although the interaction between Ahr and MAF has been only implicated in type 1 regulatory T cells (<xref rid="B159" ref-type="bibr">159</xref>), the cross talk of these two proteins may provide insight into the molecular regulation of IL-22 expression in ILC3.</p><p>Aryl hydrocarbon receptor has been shown to interact with RelB, a key component of NF-&#954;B signaling, and synergize to induce the transcription of certain genes, such as IL-6 and IL-8 in DC or macrophage (<xref rid="B160" ref-type="bibr">160</xref>, <xref rid="B161" ref-type="bibr">161</xref>). Additionally, another component of NF-&#954;B, RelA, binds to Ahr, and the interaction consequently promotes IL-6 transcription (<xref rid="B162" ref-type="bibr">162</xref>). Therefore, the interplay between Ahr and NF-&#954;B pathway might be important for ILCs since the critical function of NF-&#954;B has been investigated throughout various cell types.</p><p>Not limited to transcriptional function, Ahr has been reported to participate in posttranslational regulation in non-immune cells. It is described that Ahr acts as a component of cullin 4B ubiquitin ligase complex, which targets sex steroid receptors for degradation (<xref rid="B163" ref-type="bibr">163</xref>, <xref rid="B164" ref-type="bibr">164</xref>). More investigation directed to confirm and extend this non-genomic function of Ahr in ILC and other cell types will be necessary to understand how Ahr is linked to protein degradation in different contexts.</p><p>In non-immune cells, Ahr exhibits a rhythmic expression, and its sensitivity to Ahr ligands is time-dependent (<xref rid="B165" ref-type="bibr">165</xref>). Reciprocally, genes associated with circadian clock and the behavioral responses of mice to circadian clock are regulated by Ahr (<xref rid="B165" ref-type="bibr">165</xref>). Ahr has been shown to interact with Bmal1, which forms a complex with Clock to facilitate the transcription of circadian genes (<xref rid="B166" ref-type="bibr">166</xref>&#8211;<xref rid="B168" ref-type="bibr">168</xref>). ILC2 activation and consequent eosinophil recruitment is responsive to the circadian clock, suggesting a conserved circadian mechanism in ILCs (<xref rid="B25" ref-type="bibr">25</xref>). Understanding of the synergetic function of Ahr and circadian signaling could improve our understanding of the basic biology of ILCs, and provide new targets of interest for regulation of ILCs.</p></sec></sec><sec id="S7"><title>Translational Potential of Ahr in ILCs</title><p>Changes in ILCs have been reported in the patients with IBD. IL-22-producing ILC3 decreased in the intestine of Crohn&#8217;s patients (<xref rid="B115" ref-type="bibr">115</xref>, <xref rid="B169" ref-type="bibr">169</xref>, <xref rid="B170" ref-type="bibr">170</xref>), in line with the protective role of IL-22 on the integrity of gut barrier which has been implicated several mouse models (<xref rid="B171" ref-type="bibr">171</xref>). Other studies also reveal that IL-22 produced by ILC3 increased in inflammatory sites of the colons in both CD and UC patients (<xref rid="B122" ref-type="bibr">122</xref>, <xref rid="B172" ref-type="bibr">172</xref>), which might be due to a compensatory response of the host to inflammation but also might reveal the pathological aspects of ILC3, especially NCR<sup>+</sup> ILC3 (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>). The MHC-II expression on ILC3 is critical to induce T cell tolerance to gut commensal bacteria and avoid overt inflammation. It has been shown that pediatric IBD patients have reduced MHC-II expression on colonic ILC3, consistent with the model that compromised ILC3 regulatory function can lead to T cell-mediated inflammation (<xref rid="B146" ref-type="bibr">146</xref>). It has been shown that the expression of Ahr is reduced in the gut tissues from IBD patients compared to healthy controls (<xref rid="B173" ref-type="bibr">173</xref>). Accordingly, treatment of Ahr ligand ameliorated the pathology of several mouse colitis models, including 2,4,6-trinitrobenzenesulfonic acid (TNBS)-, DSS-, and T cell transfer-induced colitis, in which IL-22 is required (<xref rid="B173" ref-type="bibr">173</xref>, <xref rid="B174" ref-type="bibr">174</xref>). Considering the role of Ahr in the maintenance of gut ILC3 and IL-22 production by ILC3, Ahr pathway could be potentially manipulated to regulate gut inflammation by increasing ILC3 in the gut of IBD patients. However, given the different functions between NCR<sup>+</sup> ILC3 and NCR<sup>&#8722;</sup> ILC3, special considerations are needed while targeting the Ahr pathway in IBD.</p><p>Type 2 immunity has been considered to mediate ulcerative colitis in human, which has been modeled by oxazolone-induced colitis in mice (<xref rid="B175" ref-type="bibr">175</xref>). A known Ahr ligand, 3,3&#8217;-Diindolylmethane, has been found to alleviate oxazolone-induced colitis, probably through inhibition of Th2/Th17&#8201;cells and induction of Treg cells (<xref rid="B176" ref-type="bibr">176</xref>). Since ILC2 express large amounts of type 2 cytokines, this population could potentially play a pathogenic role in ulcerative colitis (<xref rid="B177" ref-type="bibr">177</xref>). Despite the reduced expression of Ahr in IBD, the role of Ahr in ILC2 and disease pathogenesis remains to be determined. In addition, it will be of interest to investigate the balance between ILC2 (or type 2 immunity) and ILC3 in colitis. IL-33, a cytokine that acts on ILC2 and Th2 to promote the cytokine production, increased in IBD patients and in experimental colitis models of mice, including TNBS and DSS model (<xref rid="B178" ref-type="bibr">178</xref>). Ablation of IL-33-ST2 pathway relieves experimental colitis in mice. Of note, IL-33 and soluble ST2 have been shown increased in the colons of IBD patients (<xref rid="B179" ref-type="bibr">179</xref>), in line with the proinflammatory role of type 2 immunity. Thus, the functions of ILC2 and ILC3 in colitis could be dissected into two phases as ILC2 initiate the pathology <italic>via</italic> IL-13 (<xref rid="B177" ref-type="bibr">177</xref>), while ILC3, probably through IL-22, facilitate the tissue repair in the later phase of disease. However, IL-22 could also participate in the gut inflammation, highlighting its &#8220;double-edged sword&#8221; nature (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B180" ref-type="bibr">180</xref>). A recent study reveals that IL-33 stimulates ILC2 to secrete amphiregulin to promote tissue repair in experimental colitis (<xref rid="B42" ref-type="bibr">42</xref>), suggesting ILC2 at different stage of the disease and/or some subset of ILC2 (i.e., amphiregulin<sup>+</sup> ILC2) may have protective function in the resolution of colitis as well.</p><p>Allergic asthma is a chronic inflammatory disease, in which type 2 cytokines, IL-4, IL-5, and IL-13 are associated with the pathology (<xref rid="B181" ref-type="bibr">181</xref>). These type 2 cytokines are required for IgE response, recruitment of eosinophils, and mucus production. ILC2 have been implicated in asthma, since ILC2 produce large amounts of IL-5 and IL-13, as well as IL-4 under certain context, in response to IL-33, IL-25, and TSLP (<xref rid="B182" ref-type="bibr">182</xref>). Additionally, recent study showed that ILC2 increase in the airways of severe asthma patients, suggesting ILC2 may contribute to airway inflammation in mouse and human (<xref rid="B183" ref-type="bibr">183</xref>). Although the function of Ahr in ILC2 remains to be determined, several Ahr ligands have been reported to suppress allergic airway inflammation in different mouse models, through suppressing type 2 cytokines, IL-4 and IL-5, production, eosinophilia, and specific IgE expression (<xref rid="B184" ref-type="bibr">184</xref>&#8211;<xref rid="B186" ref-type="bibr">186</xref>). Thus, study of the role of Ahr in ILC2 would provide another potential target for clinical intervention in airway inflammation, like asthma. Although type 2 cytokines have been well documented in asthma, elevated IL-17 has been noticed clinically (<xref rid="B187" ref-type="bibr">187</xref>). Given that IL-25 can induce a population of lung ILC2 with IL-17-producing ability, the potential role of this special ILC2 subset in the pathology of asthma in humans needs to be studied in the future.</p><p>Both pro- and antitumor action of Ahr has been implicated (<xref rid="B188" ref-type="bibr">188</xref>), and the potential function of Ahr in ILC-mediated tumor immunology remains largely unknown. Ahr has been demonstrated to promote the antitumor activity of NK cells (<xref rid="B103" ref-type="bibr">103</xref>). IL-22, mainly produced by ILC3 under the steady state, has been shown to associate with increased risk in colon cancer (<xref rid="B189" ref-type="bibr">189</xref>). Accordingly, IL-22-producing ILC3 are found to promote an experimental cancer model in mice (<xref rid="B190" ref-type="bibr">190</xref>). Therefore, understanding of the precise function of Ahr in ILCs in cancer needs to be carefully studied.</p></sec><sec id="S8"><title>Concluding Remarks</title><p>The tissue microenvironment may be involved in regulating the differentiation, homeostasis, and function of ILCs. Thus, the expression and activity of Ahr in ILCs from different organs under the steady state need to be carefully considered when designing therapeutics to target Ahr. Furthermore, it will be of great interest to investigate whether the Ahr level/activity in ILCs can be changed under different contexts, like in infection, inflammation, and/or cancers.</p><p>Cell-intrinsic role of Ahr in ILCs has to be determined given the broad expression of Ahr in other cell types. The molecular mechanism by which Ahr regulates the development or homeostasis of ILCs remains to be explored. Mechanistic insights of Ahr expression and/or activity in various ILC subsets or any given ILCs in different tissues are important for designing targeted strategy to modulate the Ahr function pharmacologically. It is of interest to investigate whether various ILCs have different sensitivity to Ahr ligand, or unique machinery to uptake Ahr ligand. Furthermore, single cell-omics studies involving RNA-seq and ATAC-seq analyses, together with ChIP-seq analysis of Ahr, will delineate the functional pattern and role of Ahr in regulating transcriptional landscape of ILCs. Identification of Ahr-binding partners in ILCs will provide insights into the mechanism by which Ahr cooperates with other factors to differentially regulate gene expression. These molecular findings could uncover more specific and effective therapeutic targets on the Ahr pathway, in cell-type/tissue-specific manner, in disease treatment and prevention.</p></sec><sec id="S9"><title>Author Contributions</title><p>SL wrote the manuscript with JB&#8217;s contribution. LZ supervised the research and edited the manuscript.</p></sec><sec id="S10"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer MC and handling editor declared their shared affiliation.</p></sec></body><back><ack><p>The authors thank the entire LZ laboratory their help and suggestions. The work was supported by the National Institutes of Health (AI132391 and DK105562 to LZ), and by a Cancer Research Institute Investigator Award (LZ). LZ is a Pew Scholar in Biomedical Sciences, supported by the Pew Charitable Trusts, and an Investigator in the Pathogenesis of Infectious Disease, supported by Burroughs Wellcome Fund.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebbo</surname><given-names>M</given-names></name><name><surname>Crinier</surname><given-names>A</given-names></name><name><surname>Vely</surname><given-names>F</given-names></name><name><surname>Vivier</surname><given-names>E</given-names></name></person-group>. <article-title>Innate lymphoid cells: major players in inflammatory diseases</article-title>. <source>Nat Rev Immunol</source> (<year>2017</year>) <volume>17</volume>(<issue>11</issue>):<fpage>665</fpage>&#8211;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1038/nri.2017.86</pub-id><?supplied-pmid 28804130?><pub-id pub-id-type="pmid">28804130</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname><given-names>CSN</given-names></name><name><surname>Artis</surname><given-names>D</given-names></name></person-group>. <article-title>Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>7</issue>):<fpage>765</fpage>&#8211;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3489</pub-id><?supplied-pmid 27328006?><pub-id pub-id-type="pmid">27328006</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>DF</given-names></name><name><surname>Zhu</surname><given-names>JF</given-names></name></person-group>. <article-title>Dynamic balance between master transcription factors determines the fates and functions of CD4 T cell and innate lymphoid cell subsets</article-title>. <source>J Exp Med</source> (<year>2017</year>) <volume>214</volume>(<issue>7</issue>):<fpage>1861</fpage>&#8211;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20170494</pub-id><?supplied-pmid 28630089?><pub-id pub-id-type="pmid">28630089</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Xia</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Regulatory innate lymphoid cells control innate intestinal inflammation</article-title>. <source>Cell</source> (<year>2017</year>) <volume>171</volume>(<issue>1</issue>):<fpage>201</fpage>&#8211;<lpage>16.e18</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2017.07.027</pub-id><pub-id pub-id-type="pmid">28844693</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname><given-names>CSN</given-names></name><name><surname>Flach</surname><given-names>M</given-names></name><name><surname>Mohle</surname><given-names>L</given-names></name><name><surname>Rogell</surname><given-names>L</given-names></name><name><surname>Hoyler</surname><given-names>T</given-names></name><name><surname>Ebert</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages</article-title>. <source>Cell</source> (<year>2014</year>) <volume>157</volume>(<issue>2</issue>):<fpage>340</fpage>&#8211;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2014.03.030</pub-id><?supplied-pmid 24725403?><pub-id pub-id-type="pmid">24725403</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattner</surname><given-names>J</given-names></name><name><surname>Wirtz</surname><given-names>S</given-names></name></person-group>. <article-title>Friend or foe? The ambiguous role of innate lymphoid cells in cancer development</article-title>. <source>Trends Immunol</source> (<year>2017</year>) <volume>38</volume>(<issue>1</issue>):<fpage>29</fpage>&#8211;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2016.10.004</pub-id><?supplied-pmid 27810463?><pub-id pub-id-type="pmid">27810463</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bostick</surname><given-names>JW</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name></person-group>. <article-title>Innate lymphoid cells in intestinal immunity and inflammation</article-title>. <source>Cell Mol Life Sci</source> (<year>2016</year>) <volume>73</volume>(<issue>2</issue>):<fpage>237</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1007/s00018-015-2055-3</pub-id><?supplied-pmid 26459449?><pub-id pub-id-type="pmid">26459449</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>HY</given-names></name><name><surname>Sciume</surname><given-names>G</given-names></name><name><surname>Mikami</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>LY</given-names></name><name><surname>Sun</surname><given-names>HW</given-names></name><name><surname>Brooks</surname><given-names>SR</given-names></name><etal/></person-group>
<article-title>Developmental acquisition of regulomes underlies innate lymphoid cell functionality</article-title>. <source>Cell</source> (<year>2016</year>) <volume>165</volume>(<issue>5</issue>):<fpage>1120</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2016.04.029</pub-id><?supplied-pmid 27156451?><pub-id pub-id-type="pmid">27156451</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name></person-group>. <article-title>AHR function in lymphocytes: emerging concepts</article-title>. <source>Trends Immunol</source> (<year>2016</year>) <volume>37</volume>(<issue>1</issue>):<fpage>17</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2015.11.007</pub-id><?supplied-pmid 26700314?><pub-id pub-id-type="pmid">26700314</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>Colonna</surname><given-names>M</given-names></name></person-group>. <article-title>Aryl hydrocarbon receptor: linking environment to immunity</article-title>. <source>Semin Immunol</source> (<year>2015</year>) <volume>27</volume>(<issue>5</issue>):<fpage>310</fpage>&#8211;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1016/j.smim.2015.10.002</pub-id><?supplied-pmid 26561251?><pub-id pub-id-type="pmid">26561251</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockinger</surname><given-names>B</given-names></name><name><surname>Di Meglio</surname><given-names>P</given-names></name><name><surname>Gialitakis</surname><given-names>M</given-names></name><name><surname>Duarte</surname><given-names>JH</given-names></name></person-group>. <article-title>The aryl hydrocarbon receptor: multitasking in the immune system</article-title>. <source>Annu Rev Immunol</source> (<year>2014</year>) <volume>32</volume>:<fpage>403</fpage>&#8211;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120245</pub-id><?supplied-pmid 24655296?><pub-id pub-id-type="pmid">24655296</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiss</surname><given-names>EA</given-names></name><name><surname>Vonarbourg</surname><given-names>C</given-names></name><name><surname>Kopfmann</surname><given-names>S</given-names></name><name><surname>Hobeika</surname><given-names>E</given-names></name><name><surname>Finke</surname><given-names>D</given-names></name><name><surname>Esser</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles</article-title>. <source>Science</source> (<year>2011</year>) <volume>334</volume>(<issue>6062</issue>):<fpage>1561</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1126/science.1214914</pub-id><?supplied-pmid 22033518?><pub-id pub-id-type="pmid">22033518</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>J</given-names></name><name><surname>Heller</surname><given-names>JJ</given-names></name><name><surname>Guo</surname><given-names>XH</given-names></name><name><surname>Chen</surname><given-names>ZME</given-names></name><name><surname>Fish</surname><given-names>K</given-names></name><name><surname>Fu</surname><given-names>YX</given-names></name><etal/></person-group>
<article-title>The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>36</volume>(<issue>1</issue>):<fpage>92</fpage>&#8211;<lpage>104</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2011.11.011</pub-id><?supplied-pmid 22177117?><pub-id pub-id-type="pmid">22177117</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Cella</surname><given-names>M</given-names></name><name><surname>McDonald</surname><given-names>KG</given-names></name><name><surname>Garlanda</surname><given-names>C</given-names></name><name><surname>Kennedy</surname><given-names>GD</given-names></name><name><surname>Nukaya</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch</article-title>. <source>Nat Immunol</source> (<year>2012</year>) <volume>13</volume>(<issue>2</issue>):<fpage>144</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2187</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberl</surname><given-names>G</given-names></name><name><surname>Di Santo</surname><given-names>JP</given-names></name><name><surname>Vivier</surname><given-names>E</given-names></name></person-group>
<article-title>The brave new world of innate lymphoid cells</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>(<issue>1</issue>):<fpage>1</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3059</pub-id><pub-id pub-id-type="pmid">25521670</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Deng</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Ruhn</surname><given-names>KA</given-names></name><name><surname>Zhang</surname><given-names>CC</given-names></name><etal/></person-group>
<article-title>The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor</article-title>. <source>Elife</source> (<year>2014</year>) <volume>3</volume>:<fpage>e04406</fpage>.<pub-id pub-id-type="doi">10.7554/eLife.04406</pub-id><?supplied-pmid 25310240?><pub-id pub-id-type="pmid">25310240</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>JH</given-names></name><name><surname>Freud</surname><given-names>AG</given-names></name><name><surname>Caligiuri</surname><given-names>MA</given-names></name></person-group>. <article-title>Location and cellular stages of natural killer cell development</article-title>. <source>Trends Immunol</source> (<year>2013</year>) <volume>34</volume>(<issue>12</issue>):<fpage>573</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2013.07.005</pub-id><?supplied-pmid 24055329?><pub-id pub-id-type="pmid">24055329</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>A</given-names></name></person-group>
<article-title>ILC1s in tissue inflammation and infection</article-title>. <source>Front Immunol</source> (<year>2016</year>) <volume>7</volume>:<fpage>104</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2016.00104</pub-id><pub-id pub-id-type="pmid">27047491</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname><given-names>MJ</given-names></name><name><surname>Weinmann</surname><given-names>AS</given-names></name><name><surname>Matsuda</surname><given-names>JL</given-names></name><name><surname>Salomon</surname><given-names>R</given-names></name><name><surname>Farnham</surname><given-names>PJ</given-names></name><name><surname>Biron</surname><given-names>CA</given-names></name><etal/></person-group>
<article-title>T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells</article-title>. <source>Immunity</source> (<year>2004</year>) <volume>20</volume>(<issue>4</issue>):<fpage>477</fpage>&#8211;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(04)00076-7</pub-id><?supplied-pmid 15084276?><pub-id pub-id-type="pmid">15084276</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Helden</surname><given-names>MJ</given-names></name><name><surname>Goossens</surname><given-names>S</given-names></name><name><surname>Daussy</surname><given-names>C</given-names></name><name><surname>Mathieu</surname><given-names>AL</given-names></name><name><surname>Faure</surname><given-names>F</given-names></name><name><surname>Marcais</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Terminal NK cell maturation is controlled by concerted actions of T-bet and Zeb2 and is essential for melanoma rejection</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>(<issue>12</issue>):<fpage>2015</fpage>&#8211;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20150809</pub-id><?supplied-pmid 26503444?><pub-id pub-id-type="pmid">26503444</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dadi</surname><given-names>S</given-names></name><name><surname>Chhangawala</surname><given-names>S</given-names></name><name><surname>Whitlock</surname><given-names>BM</given-names></name><name><surname>Franklin</surname><given-names>RA</given-names></name><name><surname>Luo</surname><given-names>CT</given-names></name><name><surname>Oh</surname><given-names>SA</given-names></name><etal/></person-group>
<article-title>Cancer immunosurveillance by tissue-resident innate lymphoid cells and innate-like T cells</article-title>. <source>Cell</source> (<year>2016</year>) <volume>164</volume>(<issue>3</issue>):<fpage>365</fpage>&#8211;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2016.01.002</pub-id><?supplied-pmid 26806130?><pub-id pub-id-type="pmid">26806130</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerwenka</surname><given-names>A</given-names></name><name><surname>Lanier</surname><given-names>LL</given-names></name></person-group>. <article-title>Natural killer cells, viruses and cancer</article-title>. <source>Nat Rev Immunol</source> (<year>2001</year>) <volume>1</volume>(<issue>1</issue>):<fpage>41</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/35095564</pub-id><?supplied-pmid 11905813?><pub-id pub-id-type="pmid">11905813</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spits</surname><given-names>H</given-names></name><name><surname>Bernink</surname><given-names>JH</given-names></name><name><surname>Lanier</surname><given-names>L</given-names></name></person-group>. <article-title>NK cells and type 1 innate lymphoid cells: partners in host defense</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>7</issue>):<fpage>758</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3482</pub-id><?supplied-pmid 27328005?><pub-id pub-id-type="pmid">27328005</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>A</given-names></name><name><surname>Vermi</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Lonardi</surname><given-names>S</given-names></name><name><surname>Gilfillan</surname><given-names>S</given-names></name><name><surname>Newberry</surname><given-names>RD</given-names></name><etal/></person-group>
<article-title>Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>(<issue>4</issue>):<fpage>769</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.02.010</pub-id><pub-id pub-id-type="pmid">23453631</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nussbaum</surname><given-names>JC</given-names></name><name><surname>Van Dyken</surname><given-names>SJ</given-names></name><name><surname>von Moltke</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>LE</given-names></name><name><surname>Mohapatra</surname><given-names>A</given-names></name><name><surname>Molofsky</surname><given-names>AB</given-names></name><etal/></person-group>
<article-title>Type 2 innate lymphoid cells control eosinophil homeostasis</article-title>. <source>Nature</source> (<year>2013</year>) <volume>502</volume>(<issue>7470</issue>):<fpage>245</fpage>.<pub-id pub-id-type="doi">10.1038/nature12526</pub-id><?supplied-pmid 24037376?><pub-id pub-id-type="pmid">24037376</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halim</surname><given-names>TYF</given-names></name><name><surname>MacLaren</surname><given-names>A</given-names></name><name><surname>Romanish</surname><given-names>MT</given-names></name><name><surname>Gold</surname><given-names>MJ</given-names></name><name><surname>McNagny</surname><given-names>KM</given-names></name><name><surname>Takei</surname><given-names>F</given-names></name></person-group>. <article-title>Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>37</volume>(<issue>3</issue>):<fpage>463</fpage>&#8211;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.06.012</pub-id><?supplied-pmid 22981535?><pub-id pub-id-type="pmid">22981535</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neill</surname><given-names>DR</given-names></name><name><surname>Wong</surname><given-names>SH</given-names></name><name><surname>Bellosi</surname><given-names>A</given-names></name><name><surname>Flynn</surname><given-names>RJ</given-names></name><name><surname>Daly</surname><given-names>M</given-names></name><name><surname>Langford</surname><given-names>TK</given-names></name><etal/></person-group>
<article-title>Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity</article-title>. <source>Nature</source> (<year>2010</year>) <volume>464</volume>(<issue>7293</issue>):<fpage>1367</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1038/nature08900</pub-id><?supplied-pmid 20200518?><pub-id pub-id-type="pmid">20200518</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoyler</surname><given-names>T</given-names></name><name><surname>Klose</surname><given-names>CS</given-names></name><name><surname>Souabni</surname><given-names>A</given-names></name><name><surname>Turqueti-Neves</surname><given-names>A</given-names></name><name><surname>Pfeifer</surname><given-names>D</given-names></name><name><surname>Rawlins</surname><given-names>EL</given-names></name><etal/></person-group>
<article-title>The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>37</volume>(<issue>4</issue>):<fpage>634</fpage>&#8211;<lpage>48</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.06.020</pub-id><?supplied-pmid 23063333?><pub-id pub-id-type="pmid">23063333</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spooner</surname><given-names>CJ</given-names></name><name><surname>Lesch</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>D</given-names></name><name><surname>Khan</surname><given-names>AA</given-names></name><name><surname>Abbas</surname><given-names>A</given-names></name><name><surname>Ramirez-Carrozzi</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>(<issue>12</issue>):<fpage>1229</fpage>&#8211;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2743</pub-id><?supplied-pmid 24141388?><pub-id pub-id-type="pmid">24141388</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Monticelli</surname><given-names>LA</given-names></name><name><surname>Saenz</surname><given-names>SA</given-names></name><name><surname>Chi</surname><given-names>AWS</given-names></name><name><surname>Sonnenberg</surname><given-names>GF</given-names></name><name><surname>Tang</surname><given-names>JB</given-names></name><etal/></person-group>
<article-title>T cell factor 1 is required for group 2 innate lymphoid cell generation</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>(<issue>4</issue>):<fpage>694</fpage>&#8211;<lpage>704</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.12.003</pub-id><?supplied-pmid 23601684?><pub-id pub-id-type="pmid">23601684</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Califano</surname><given-names>D</given-names></name><name><surname>Cho</surname><given-names>JJ</given-names></name><name><surname>Uddin</surname><given-names>MN</given-names></name><name><surname>Lorentsen</surname><given-names>KJ</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Bhandoola</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Transcription factor Bcl11b controls identity and function of mature type 2 innate lymphoid cells</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>43</volume>(<issue>2</issue>):<fpage>354</fpage>&#8211;<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.07.005</pub-id><?supplied-pmid 26231117?><pub-id pub-id-type="pmid">26231117</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Clare</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>JX</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Brandt</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>(<issue>6</issue>):<fpage>865</fpage>&#8211;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20142318</pub-id><?supplied-pmid 25964371?><pub-id pub-id-type="pmid">25964371</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>JA</given-names></name><name><surname>Oliphant</surname><given-names>CJ</given-names></name><name><surname>Englezakis</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Clare</surname><given-names>S</given-names></name><name><surname>Rodewald</surname><given-names>HR</given-names></name><etal/></person-group>
<article-title>Bcl11b is essential for group 2 innate lymphoid cell development</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>(<issue>6</issue>):<fpage>875</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20142224</pub-id><?supplied-pmid 25964370?><pub-id pub-id-type="pmid">25964370</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>KN</given-names></name><name><surname>Xu</surname><given-names>XY</given-names></name><name><surname>Pasha</surname><given-names>MA</given-names></name><name><surname>Siebel</surname><given-names>CW</given-names></name><name><surname>Costello</surname><given-names>A</given-names></name><name><surname>Haczku</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Cutting edge: notch signaling promotes the plasticity of group-2 innate lymphoid cells</article-title>. <source>J Immunol</source> (<year>2017</year>) <volume>198</volume>(<issue>5</issue>):<fpage>1798</fpage>&#8211;<lpage>803</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1601421</pub-id><?supplied-pmid 28115527?><pub-id pub-id-type="pmid">28115527</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salimi</surname><given-names>M</given-names></name><name><surname>Barlow</surname><given-names>JL</given-names></name><name><surname>Saunders</surname><given-names>SP</given-names></name><name><surname>Xue</surname><given-names>LZ</given-names></name><name><surname>Gutowska-Owsiak</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>XW</given-names></name><etal/></person-group>
<article-title>A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>(<issue>13</issue>):<fpage>2939</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20130351</pub-id><?supplied-pmid 24323357?><pub-id pub-id-type="pmid">24323357</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Moltke</surname><given-names>J</given-names></name><name><surname>Ji</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>HE</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name></person-group>. <article-title>Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit</article-title>. <source>Nature</source> (<year>2016</year>) <volume>529</volume>(<issue>7585</issue>):<fpage>221</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nature16161</pub-id><?supplied-pmid 26675736?><pub-id pub-id-type="pmid">26675736</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monticelli</surname><given-names>LA</given-names></name><name><surname>Sonnenberg</surname><given-names>GF</given-names></name><name><surname>Abt</surname><given-names>MC</given-names></name><name><surname>Alenghat</surname><given-names>T</given-names></name><name><surname>Ziegler</surname><given-names>CG</given-names></name><name><surname>Doering</surname><given-names>TA</given-names></name><etal/></person-group>
<article-title>Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus</article-title>. <source>Nat Immunol</source> (<year>2011</year>) <volume>12</volume>(<issue>11</issue>):<fpage>1045</fpage>&#8211;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1031/ni.2131</pub-id><?supplied-pmid 21946417?><pub-id pub-id-type="pmid">21946417</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mjosberg</surname><given-names>JM</given-names></name><name><surname>Trifari</surname><given-names>S</given-names></name><name><surname>Crellin</surname><given-names>NK</given-names></name><name><surname>Peters</surname><given-names>CP</given-names></name><name><surname>van Drunen</surname><given-names>CM</given-names></name><name><surname>Piet</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161</article-title>. <source>Nat Immunol</source> (<year>2011</year>) <volume>12</volume>(<issue>11</issue>):<fpage>1055</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2104</pub-id><?supplied-pmid 21909091?><pub-id pub-id-type="pmid">21909091</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>BS</given-names></name><name><surname>Siracusa</surname><given-names>MC</given-names></name><name><surname>Saenz</surname><given-names>SA</given-names></name><name><surname>Noti</surname><given-names>M</given-names></name><name><surname>Monticelli</surname><given-names>LA</given-names></name><name><surname>Sonnenberg</surname><given-names>GF</given-names></name><etal/></person-group>
<article-title>TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation</article-title>. <source>Sci Transl Med</source> (<year>2013</year>) <volume>5</volume>(<issue>170</issue>):<fpage>170ra16</fpage>.<pub-id pub-id-type="doi">10.1126/scitranslmed.3005374</pub-id><?supplied-pmid 23363980?><pub-id pub-id-type="pmid">23363980</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JE</given-names></name><name><surname>Morrison</surname><given-names>PJ</given-names></name><name><surname>Wilhelm</surname><given-names>C</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Ahlfors</surname><given-names>H</given-names></name><name><surname>Renauld</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>(<issue>13</issue>):<fpage>2951</fpage>&#8211;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20130071</pub-id><?supplied-pmid 24249111?><pub-id pub-id-type="pmid">24249111</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohapatra</surname><given-names>A</given-names></name><name><surname>Van Dyken</surname><given-names>SJ</given-names></name><name><surname>Schneider</surname><given-names>C</given-names></name><name><surname>Nussbaum</surname><given-names>JC</given-names></name><name><surname>Liang</surname><given-names>HE</given-names></name><name><surname>Locksley</surname><given-names>RM</given-names></name></person-group>. <article-title>Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis</article-title>. <source>Mucosal Immunol</source> (<year>2016</year>) <volume>9</volume>(<issue>1</issue>):<fpage>275</fpage>&#8211;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2015.59</pub-id><?supplied-pmid 26129648?><pub-id pub-id-type="pmid">26129648</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monticelli</surname><given-names>LA</given-names></name><name><surname>Osborne</surname><given-names>LC</given-names></name><name><surname>Noti</surname><given-names>M</given-names></name><name><surname>Tran</surname><given-names>SV</given-names></name><name><surname>Zaiss</surname><given-names>DM</given-names></name><name><surname>Artis</surname><given-names>D</given-names></name></person-group>. <article-title>IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2015</year>) <volume>112</volume>(<issue>34</issue>):<fpage>10762</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1509070112</pub-id><?supplied-pmid 26243875?><pub-id pub-id-type="pmid">26243875</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MW</given-names></name><name><surname>Odegaard</surname><given-names>JI</given-names></name><name><surname>Mukundan</surname><given-names>L</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Molofsky</surname><given-names>AB</given-names></name><name><surname>Nussbaum</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>Activated type 2 innate lymphoid cells regulate beige fat biogenesis</article-title>. <source>Cell</source> (<year>2015</year>) <volume>160</volume>(<issue>1&#8211;2</issue>):<fpage>74</fpage>&#8211;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2014.12.011</pub-id><?supplied-pmid 25543153?><pub-id pub-id-type="pmid">25543153</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brestoff</surname><given-names>JR</given-names></name><name><surname>Kim</surname><given-names>BS</given-names></name><name><surname>Saenz</surname><given-names>SA</given-names></name><name><surname>Stine</surname><given-names>RR</given-names></name><name><surname>Monticelli</surname><given-names>LA</given-names></name><name><surname>Sonnenberg</surname><given-names>GF</given-names></name><etal/></person-group>
<article-title>Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity</article-title>. <source>Nature</source> (<year>2015</year>) <volume>519</volume>(<issue>7542</issue>):<fpage>242</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/nature14115</pub-id><?supplied-pmid 25533952?><pub-id pub-id-type="pmid">25533952</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazenberg</surname><given-names>MD</given-names></name><name><surname>Spits</surname><given-names>H</given-names></name></person-group>. <article-title>Human innate lymphoid cells</article-title>. <source>Blood</source> (<year>2014</year>) <volume>124</volume>(<issue>5</issue>):<fpage>700</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2013-11-427781</pub-id><?supplied-pmid 24778151?><pub-id pub-id-type="pmid">24778151</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasteiger</surname><given-names>G</given-names></name><name><surname>Fan</surname><given-names>XY</given-names></name><name><surname>Dikiy</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Rudensky</surname><given-names>AY</given-names></name></person-group>. <article-title>Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs</article-title>. <source>Science</source> (<year>2015</year>) <volume>350</volume>(<issue>6263</issue>):<fpage>981</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1126/science.aac9593</pub-id><?supplied-pmid 26472762?><pub-id pub-id-type="pmid">26472762</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>C</given-names></name><name><surname>Cui</surname><given-names>KR</given-names></name><name><surname>Wilhelm</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>GQ</given-names></name><name><surname>Mao</surname><given-names>KR</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>2</issue>):<fpage>169</fpage>&#8211;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3318</pub-id><?supplied-pmid 26595886?><pub-id pub-id-type="pmid">26595886</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MY</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>McConnell</surname><given-names>F</given-names></name><name><surname>Lane</surname><given-names>P</given-names></name></person-group>. <article-title>Lymphoid tissue inducer cells: architects of CD4 immune responses in mice and men</article-title>. <source>Clin Exp Immunol</source> (<year>2009</year>) <volume>157</volume>(<issue>1</issue>):<fpage>20</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2009.03932.x</pub-id><?supplied-pmid 19659766?><pub-id pub-id-type="pmid">19659766</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cherrier</surname><given-names>M</given-names></name><name><surname>Sawa</surname><given-names>S</given-names></name><name><surname>Eberl</surname><given-names>G</given-names></name></person-group>
<article-title>Notch, Id2, and RORgammat sequentially orchestrate the fetal development of lymphoid tissue inducer cells</article-title>. <source>J Exp Med</source> (<year>2012</year>) <volume>209</volume>(<issue>4</issue>):<fpage>729</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20111594</pub-id><pub-id pub-id-type="pmid">22430492</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>II</given-names></name><name><surname>Diehl</surname><given-names>GE</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group>. <article-title>Lymphoid tissue inducer cells in intestinal immunity</article-title>. <source>Curr Top Microbiol Immunol</source> (<year>2006</year>) <volume>308</volume>:<fpage>59</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1007/3-540-30657-9_3</pub-id><?supplied-pmid 16922086?><pub-id pub-id-type="pmid">16922086</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takatori</surname><given-names>H</given-names></name><name><surname>Kanno</surname><given-names>Y</given-names></name><name><surname>Watford</surname><given-names>WT</given-names></name><name><surname>Tato</surname><given-names>CM</given-names></name><name><surname>Weiss</surname><given-names>G</given-names></name><name><surname>Ivanov</surname><given-names>II</given-names></name><etal/></person-group>
<article-title>Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22</article-title>. <source>J Exp Med</source> (<year>2009</year>) <volume>206</volume>(<issue>1</issue>):<fpage>35</fpage>&#8211;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20072713</pub-id><?supplied-pmid 19114665?><pub-id pub-id-type="pmid">19114665</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberl</surname><given-names>G</given-names></name><name><surname>Marmon</surname><given-names>S</given-names></name><name><surname>Sunshine</surname><given-names>MJ</given-names></name><name><surname>Rennert</surname><given-names>PD</given-names></name><name><surname>Choi</surname><given-names>YW</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name></person-group>
<article-title>An essential function for the nuclear receptor ROR gamma t in the generation of fetal lymphoid tissue inducer cells</article-title>. <source>Nat Immunol</source> (<year>2004</year>) <volume>5</volume>(<issue>1</issue>):<fpage>64</fpage>&#8211;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1038/ni1022</pub-id><pub-id pub-id-type="pmid">14691482</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname><given-names>CS</given-names></name><name><surname>Kiss</surname><given-names>EA</given-names></name><name><surname>Schwierzeck</surname><given-names>V</given-names></name><name><surname>Ebert</surname><given-names>K</given-names></name><name><surname>Hoyler</surname><given-names>T</given-names></name><name><surname>d&#8217;Hargues</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>A T-bet gradient controls the fate and function of CCR6-RORgammat+ innate lymphoid cells</article-title>. <source>Nature</source> (<year>2013</year>) <volume>494</volume>(<issue>7436</issue>):<fpage>261</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nature11813</pub-id><pub-id pub-id-type="pmid">23334414</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mortha</surname><given-names>A</given-names></name><name><surname>Chudnovskiy</surname><given-names>A</given-names></name><name><surname>Hashimoto</surname><given-names>D</given-names></name><name><surname>Bogunovic</surname><given-names>M</given-names></name><name><surname>Spencer</surname><given-names>SP</given-names></name><name><surname>Belkaid</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis</article-title>. <source>Science</source> (<year>2014</year>) <volume>343</volume>(<issue>6178</issue>):<fpage>1477</fpage>.<pub-id pub-id-type="doi">10.1126/Science.1249288</pub-id><?supplied-pmid 24625929?><pub-id pub-id-type="pmid">24625929</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yagi</surname><given-names>RJ</given-names></name><name><surname>Zhong</surname><given-names>C</given-names></name><name><surname>Northrup</surname><given-names>DL</given-names></name><name><surname>Yu</surname><given-names>F</given-names></name><name><surname>Bouladoux</surname><given-names>N</given-names></name><name><surname>Spencer</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>The transcription factor GATA3 is critical for the development of all IL-7R alpha-expressing innate lymphoid cells</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>40</volume>(<issue>3</issue>):<fpage>378</fpage>&#8211;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.01.012</pub-id><pub-id pub-id-type="pmid">24631153</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serafini</surname><given-names>N</given-names></name><name><surname>Klein Wolterink</surname><given-names>RG</given-names></name><name><surname>Satoh-Takayama</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Vosshenrich</surname><given-names>CA</given-names></name><name><surname>Hendriks</surname><given-names>RW</given-names></name><etal/></person-group>
<article-title>Gata3 drives development of RORgammat+ group 3 innate lymphoid cells</article-title>. <source>J Exp Med</source> (<year>2014</year>) <volume>211</volume>(<issue>2</issue>):<fpage>199</fpage>&#8211;<lpage>208</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20131038</pub-id><pub-id pub-id-type="pmid">24419270</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colonna</surname><given-names>M</given-names></name></person-group>. <article-title>Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>31</volume>(<issue>1</issue>):<fpage>15</fpage>&#8211;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2009.06.008</pub-id><?supplied-pmid 19604490?><pub-id pub-id-type="pmid">19604490</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnenberg</surname><given-names>GF</given-names></name><name><surname>Monticelli</surname><given-names>LA</given-names></name><name><surname>Elloso</surname><given-names>MM</given-names></name><name><surname>Fouser</surname><given-names>LA</given-names></name><name><surname>Artis</surname><given-names>D</given-names></name></person-group>. <article-title>CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>34</volume>(<issue>1</issue>):<fpage>122</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2010.12.009</pub-id><?supplied-pmid 21194981?><pub-id pub-id-type="pmid">21194981</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gladiator</surname><given-names>A</given-names></name><name><surname>Wangler</surname><given-names>N</given-names></name><name><surname>Trautwein-Weidner</surname><given-names>K</given-names></name><name><surname>LeibundGut-Landmann</surname><given-names>S</given-names></name></person-group>. <article-title>Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>(<issue>2</issue>):<fpage>521</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1202924</pub-id><?supplied-pmid 23255360?><pub-id pub-id-type="pmid">23255360</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>PP</given-names></name><name><surname>Mahlakoiv</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>I</given-names></name><name><surname>Schwierzeck</surname><given-names>V</given-names></name><name><surname>Nguyen</surname><given-names>N</given-names></name><name><surname>Guendel</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Interferon-lambda and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>(<issue>7</issue>):<fpage>698</fpage>&#8211;<lpage>707</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3180</pub-id><pub-id pub-id-type="pmid">26006013</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powell</surname><given-names>N</given-names></name><name><surname>Walker</surname><given-names>AW</given-names></name><name><surname>Stolarczyk</surname><given-names>E</given-names></name><name><surname>Canavan</surname><given-names>JB</given-names></name><name><surname>Gokmen</surname><given-names>MR</given-names></name><name><surname>Marks</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>37</volume>(<issue>4</issue>):<fpage>674</fpage>&#8211;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.09.008</pub-id><?supplied-pmid 23063332?><pub-id pub-id-type="pmid">23063332</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>J</given-names></name><name><surname>Guo</surname><given-names>XH</given-names></name><name><surname>Chen</surname><given-names>ZME</given-names></name><name><surname>He</surname><given-names>L</given-names></name><name><surname>Sonnenberg</surname><given-names>GF</given-names></name><name><surname>Artis</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>(<issue>2</issue>):<fpage>386</fpage>&#8211;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.08.002</pub-id><?supplied-pmid 23954130?><pub-id pub-id-type="pmid">23954130</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson</surname><given-names>C</given-names></name><name><surname>Thornton</surname><given-names>EE</given-names></name><name><surname>McKenzie</surname><given-names>B</given-names></name><name><surname>Schaupp</surname><given-names>AL</given-names></name><name><surname>Huskens</surname><given-names>N</given-names></name><name><surname>Griseri</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>ILC3 GM-CSF production and mobilisation orchestrate acute intestinal inflammation</article-title>. <source>Elife</source> (<year>2016</year>) <volume>5</volume>:<fpage>e10066</fpage><pub-id pub-id-type="doi">10.7554/eLife.10066</pub-id><pub-id pub-id-type="pmid">26780670</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Gilfillan</surname><given-names>S</given-names></name><name><surname>Robinette</surname><given-names>ML</given-names></name><name><surname>Newberry</surname><given-names>RD</given-names></name><name><surname>Stappenbeck</surname><given-names>TS</given-names></name><etal/></person-group>
<article-title>Unique and redundant functions of NKp46(+) ILC3s in models of intestinal inflammation</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>(<issue>11</issue>):<fpage>1869</fpage>&#8211;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20151403</pub-id><pub-id pub-id-type="pmid">26458769</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eken</surname><given-names>A</given-names></name><name><surname>Singh</surname><given-names>AK</given-names></name><name><surname>Treuting</surname><given-names>PM</given-names></name><name><surname>Oukka</surname><given-names>M</given-names></name></person-group>
<article-title>IL-23R(+) innate lymphoid cells induce colitis via interleukin-22-dependent mechanism</article-title>. <source>Mucosal Immunol</source> (<year>2014</year>) <volume>7</volume>(<issue>1</issue>):<fpage>143</fpage>&#8211;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2013.33</pub-id><pub-id pub-id-type="pmid">23715173</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouskra</surname><given-names>D</given-names></name><name><surname>Brezillon</surname><given-names>C</given-names></name><name><surname>Berard</surname><given-names>M</given-names></name><name><surname>Werts</surname><given-names>C</given-names></name><name><surname>Varona</surname><given-names>R</given-names></name><name><surname>Boneca</surname><given-names>IG</given-names></name><etal/></person-group>
<article-title>Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis</article-title>. <source>Nature</source> (<year>2008</year>) <volume>456</volume>(<issue>7221</issue>):<fpage>507</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1038/nature07450</pub-id><?supplied-pmid 18987631?><pub-id pub-id-type="pmid">18987631</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanamori</surname><given-names>Y</given-names></name><name><surname>Ishimaru</surname><given-names>K</given-names></name><name><surname>Nanno</surname><given-names>M</given-names></name><name><surname>Maki</surname><given-names>K</given-names></name><name><surname>Ikuta</surname><given-names>K</given-names></name><name><surname>Nariuchi</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit(+) IL-7R(+) Thy1(+) lympho-hemopoietic progenitors develop</article-title>. <source>J Exp Med</source> (<year>1996</year>) <volume>184</volume>(<issue>4</issue>):<fpage>1449</fpage>&#8211;<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1084/jem.184.4.1449</pub-id><pub-id pub-id-type="pmid">8879216</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>RT</given-names></name><name><surname>Lugering</surname><given-names>A</given-names></name><name><surname>Newell</surname><given-names>KA</given-names></name><name><surname>Williams</surname><given-names>IR</given-names></name></person-group>. <article-title>Intestinal cryptopatch formation in mice requires lymphotoxin alpha and the lymphotoxin beta receptor</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>173</volume>(<issue>12</issue>):<fpage>7183</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.173.12.7183</pub-id><?supplied-pmid 15585839?><pub-id pub-id-type="pmid">15585839</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lugering</surname><given-names>A</given-names></name><name><surname>Ross</surname><given-names>M</given-names></name><name><surname>Sieker</surname><given-names>M</given-names></name><name><surname>Heidemann</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>IR</given-names></name><name><surname>Domschke</surname><given-names>W</given-names></name><etal/></person-group>
<article-title>CCR6 identifies lymphoid tissue inducer cells within cryptopatches</article-title>. <source>Clin Exp Immunol</source> (<year>2010</year>) <volume>160</volume>(<issue>3</issue>):<fpage>440</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.2010.04103.x</pub-id><?supplied-pmid 20148914?><pub-id pub-id-type="pmid">20148914</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crome</surname><given-names>SQ</given-names></name><name><surname>Nguyen</surname><given-names>LT</given-names></name><name><surname>Lopez-Verges</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>SY</given-names></name><name><surname>Martin</surname><given-names>B</given-names></name><name><surname>Yam</surname><given-names>JY</given-names></name><etal/></person-group>
<article-title>A distinct innate lymphoid cell population regulates tumor-associated T cells</article-title>. <source>Nat Med</source> (<year>2017</year>) <volume>23</volume>(<issue>3</issue>):<fpage>368</fpage>&#8211;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1038/nm.4278</pub-id><?supplied-pmid 28165478?><pub-id pub-id-type="pmid">28165478</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ema</surname><given-names>M</given-names></name><name><surname>Sogawa</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>N</given-names></name><name><surname>Chujoh</surname><given-names>Y</given-names></name><name><surname>Matsushita</surname><given-names>N</given-names></name><name><surname>Gotoh</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>cDNA cloning and structure of mouse putative Ah receptor</article-title>. <source>Biochem Biophys Res Commun</source> (<year>1992</year>) <volume>184</volume>(<issue>1</issue>):<fpage>246</fpage>&#8211;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1016/0006-291X(92)91185-S</pub-id><?supplied-pmid 1314586?><pub-id pub-id-type="pmid">1314586</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burbach</surname><given-names>KM</given-names></name><name><surname>Poland</surname><given-names>A</given-names></name><name><surname>Bradfield</surname><given-names>CA</given-names></name></person-group>. <article-title>Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1992</year>) <volume>89</volume>(<issue>17</issue>):<fpage>8185</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.89.17.8185</pub-id><?supplied-pmid 1325649?><pub-id pub-id-type="pmid">1325649</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>NB</given-names></name><name><surname>Kerkvliet</surname><given-names>NI</given-names></name></person-group>. <article-title>Dioxin and immune regulation emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells</article-title>. <source>Ann N Y Acad Sci</source> (<year>2010</year>) <volume>1183</volume>:<fpage>25</fpage>&#8211;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1111/j.1749-6632.2009.05125.x</pub-id><?supplied-pmid 20146706?><pub-id pub-id-type="pmid">20146706</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zelante</surname><given-names>T</given-names></name><name><surname>Iannitti</surname><given-names>RG</given-names></name><name><surname>Cunha</surname><given-names>C</given-names></name><name><surname>De Luca</surname><given-names>A</given-names></name><name><surname>Giovannini</surname><given-names>G</given-names></name><name><surname>Pieraccini</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>(<issue>2</issue>):<fpage>372</fpage>&#8211;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.08.003</pub-id><?supplied-pmid 23973224?><pub-id pub-id-type="pmid">23973224</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bjeldanes</surname><given-names>LF</given-names></name><name><surname>Kim</surname><given-names>JY</given-names></name><name><surname>Grose</surname><given-names>KR</given-names></name><name><surname>Bartholomew</surname><given-names>JC</given-names></name><name><surname>Bradfield</surname><given-names>CA</given-names></name></person-group>. <article-title>Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1991</year>) <volume>88</volume>(<issue>21</issue>):<fpage>9543</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.88.21.9543</pub-id><?supplied-pmid 1658785?><pub-id pub-id-type="pmid">1658785</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mezrich</surname><given-names>JD</given-names></name><name><surname>Fechner</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>XJ</given-names></name><name><surname>Johnson</surname><given-names>BP</given-names></name><name><surname>Burlingham</surname><given-names>WJ</given-names></name><name><surname>Bradfield</surname><given-names>CA</given-names></name></person-group>. <article-title>An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>185</volume>(<issue>6</issue>):<fpage>3190</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0903670</pub-id><?supplied-pmid 20720200?><pub-id pub-id-type="pmid">20720200</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pongratz</surname><given-names>I</given-names></name><name><surname>Mason</surname><given-names>GG</given-names></name><name><surname>Poellinger</surname><given-names>L</given-names></name></person-group>
<article-title>Dual roles of the 90-kDa heat shock protein hsp90 in modulating functional activities of the dioxin receptor. Evidence that the dioxin receptor functionally belongs to a subclass of nuclear receptors which require hsp90 both for ligand binding activity and repression of intrinsic DNA binding activity</article-title>. <source>J Biol Chem</source> (<year>1992</year>) <volume>267</volume>(<issue>19</issue>):<fpage>13728</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="pmid">1320028</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lees</surname><given-names>MJ</given-names></name><name><surname>Peet</surname><given-names>DJ</given-names></name><name><surname>Whitelaw</surname><given-names>ML</given-names></name></person-group>. <article-title>Defining the role for XAP2 in stabilization of the dioxin receptor</article-title>. <source>J Biol Chem</source> (<year>2003</year>) <volume>278</volume>(<issue>38</issue>):<fpage>35878</fpage>&#8211;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M302430200</pub-id><?supplied-pmid 12837759?><pub-id pub-id-type="pmid">12837759</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nair</surname><given-names>SC</given-names></name><name><surname>Toran</surname><given-names>EJ</given-names></name><name><surname>Rimerman</surname><given-names>RA</given-names></name><name><surname>Hjermstad</surname><given-names>S</given-names></name><name><surname>Smithgall</surname><given-names>TE</given-names></name><name><surname>Smith</surname><given-names>DF</given-names></name></person-group>. <article-title>A pathway of multi-chaperone interactions common to diverse regulatory proteins: estrogen receptor, Fes tyrosine kinase, heat shock transcription factor HSF1, and the aryl hydrocarbon receptor</article-title>. <source>Cell Stress Chaperones</source> (<year>1996</year>) <volume>1</volume>(<issue>4</issue>):<fpage>237</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1379/1466-1268(1996)001&lt;0237:APOMCI&gt;2.3.CO;2</pub-id><?supplied-pmid 9222609?><pub-id pub-id-type="pmid">9222609</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukunaga</surname><given-names>BN</given-names></name><name><surname>Probst</surname><given-names>MR</given-names></name><name><surname>Reisz-Porszasz</surname><given-names>S</given-names></name><name><surname>Hankinson</surname><given-names>O</given-names></name></person-group>. <article-title>Identification of functional domains of the aryl hydrocarbon receptor</article-title>. <source>J Biol Chem</source> (<year>1995</year>) <volume>270</volume>(<issue>49</issue>):<fpage>29270</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.270.49.29270</pub-id><?supplied-pmid 7493958?><pub-id pub-id-type="pmid">7493958</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furman</surname><given-names>DP</given-names></name><name><surname>Oshchepkova</surname><given-names>EA</given-names></name><name><surname>Oshchepkov</surname><given-names>DY</given-names></name><name><surname>Shamanina</surname><given-names>MY</given-names></name><name><surname>Mordvinov</surname><given-names>VA</given-names></name></person-group>. <article-title>Promoters of the genes encoding the transcription factors regulating the cytokine gene expression in macrophages contain putative binding sites for aryl hydrocarbon receptor</article-title>. <source>Comput Biol Chem</source> (<year>2009</year>) <volume>33</volume>(<issue>6</issue>):<fpage>465</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.compbiolchem.2009.10.004</pub-id><?supplied-pmid 19906563?><pub-id pub-id-type="pmid">19906563</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DW</given-names></name><name><surname>Gazourian</surname><given-names>L</given-names></name><name><surname>Quadri</surname><given-names>SA</given-names></name><name><surname>Romieu-Mourez</surname><given-names>R</given-names></name><name><surname>Sherr</surname><given-names>DH</given-names></name><name><surname>Sonenshein</surname><given-names>GE</given-names></name></person-group>. <article-title>The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells</article-title>. <source>Oncogene</source> (<year>2000</year>) <volume>19</volume>(<issue>48</issue>):<fpage>5498</fpage>&#8211;<lpage>506</lpage>.<pub-id pub-id-type="doi">10.1038/sj.onc.1203945</pub-id><?supplied-pmid 11114727?><pub-id pub-id-type="pmid">11114727</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>G</given-names></name><name><surname>Qin</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Sheng</surname><given-names>X</given-names></name><name><surname>Yu</surname><given-names>Q</given-names></name><etal/></person-group>
<article-title>Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation</article-title>. <source>J Clin Invest</source> (<year>2011</year>) <volume>121</volume>(<issue>2</issue>):<fpage>658</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1172/JCI42974</pub-id><?supplied-pmid 21266776?><pub-id pub-id-type="pmid">21266776</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poland</surname><given-names>A</given-names></name><name><surname>Knutson</surname><given-names>JC</given-names></name></person-group>. <article-title>2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity</article-title>. <source>Annu Rev Pharmacol Toxicol</source> (<year>1982</year>) <volume>22</volume>:<fpage>517</fpage>&#8211;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.pa.22.040182.002505</pub-id><?supplied-pmid 6282188?><pub-id pub-id-type="pmid">6282188</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>TW</given-names></name><name><surname>Darlington</surname><given-names>LG</given-names></name></person-group>. <article-title>Endogenous kynurenines as targets for drug discovery and development</article-title>. <source>Nat Rev Drug Discov</source> (<year>2002</year>) <volume>1</volume>(<issue>8</issue>):<fpage>609</fpage>&#8211;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1038/nrd870</pub-id><?supplied-pmid 12402501?><pub-id pub-id-type="pmid">12402501</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opitz</surname><given-names>CA</given-names></name><name><surname>Litzenburger</surname><given-names>UM</given-names></name><name><surname>Sahm</surname><given-names>F</given-names></name><name><surname>Ott</surname><given-names>M</given-names></name><name><surname>Tritschler</surname><given-names>I</given-names></name><name><surname>Trump</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor</article-title>. <source>Nature</source> (<year>2011</year>) <volume>478</volume>(<issue>7368</issue>):<fpage>197</fpage>&#8211;<lpage>203</lpage>.<pub-id pub-id-type="doi">10.1038/nature10491</pub-id><?supplied-pmid 21976023?><pub-id pub-id-type="pmid">21976023</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heath-Pagliuso</surname><given-names>S</given-names></name><name><surname>Rogers</surname><given-names>WJ</given-names></name><name><surname>Tullis</surname><given-names>K</given-names></name><name><surname>Seidel</surname><given-names>SD</given-names></name><name><surname>Cenijn</surname><given-names>PH</given-names></name><name><surname>Brouwer</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Activation of the Ah receptor by tryptophan and tryptophan metabolites</article-title>. <source>Biochemistry</source> (<year>1998</year>) <volume>37</volume>(<issue>33</issue>):<fpage>11508</fpage>&#8211;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1021/bi980087p</pub-id><?supplied-pmid 9708986?><pub-id pub-id-type="pmid">9708986</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bittinger</surname><given-names>MA</given-names></name><name><surname>Nguyen</surname><given-names>LP</given-names></name><name><surname>Bradfield</surname><given-names>CA</given-names></name></person-group>. <article-title>Aspartate aminotransferase generates proagonists of the aryl hydrocarbon receptor</article-title>. <source>Mol Pharmacol</source> (<year>2003</year>) <volume>64</volume>(<issue>3</issue>):<fpage>550</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1124/mol.64.3.550</pub-id><?supplied-pmid 12920190?><pub-id pub-id-type="pmid">12920190</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rannug</surname><given-names>A</given-names></name><name><surname>Rannug</surname><given-names>U</given-names></name><name><surname>Rosenkranz</surname><given-names>HS</given-names></name><name><surname>Winqvist</surname><given-names>L</given-names></name><name><surname>Westerholm</surname><given-names>R</given-names></name><name><surname>Agurell</surname><given-names>E</given-names></name><etal/></person-group>
<article-title>Certain photooxidized derivatives of tryptophan bind with very high-affinity to the Ah receptor and are likely to be endogenous signal substances</article-title>. <source>J Biol Chem</source> (<year>1987</year>) <volume>262</volume>(<issue>32</issue>):<fpage>15422</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="pmid">2824460</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esser</surname><given-names>C</given-names></name><name><surname>Rannug</surname><given-names>A</given-names></name></person-group>
<article-title>The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology</article-title>. <source>Pharmacol Rev</source> (<year>2015</year>) <volume>67</volume>(<issue>2</issue>):<fpage>259</fpage>&#8211;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1124/pr.114.009001</pub-id><pub-id pub-id-type="pmid">25657351</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cervantes-Barragan</surname><given-names>L</given-names></name><name><surname>Chai</surname><given-names>JN</given-names></name><name><surname>Tianero</surname><given-names>MD</given-names></name><name><surname>Di Luccia</surname><given-names>B</given-names></name><name><surname>Ahern</surname><given-names>PP</given-names></name><name><surname>Merriman</surname><given-names>J</given-names></name><etal/></person-group>
<article-title><italic>Lactobacillus reuteri</italic> induces gut intraepithelial CD4+CD8alphaalpha+ T cells</article-title>. <source>Science</source> (<year>2017</year>) <volume>357</volume>(<issue>6353</issue>):<fpage>806</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="doi">10.1126/science.aah5825</pub-id><pub-id pub-id-type="pmid">28775213</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamas</surname><given-names>B</given-names></name><name><surname>Richard</surname><given-names>ML</given-names></name><name><surname>Leducq</surname><given-names>V</given-names></name><name><surname>Pham</surname><given-names>HP</given-names></name><name><surname>Michel</surname><given-names>ML</given-names></name><name><surname>Da Costa</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands</article-title>. <source>Nat Med</source> (<year>2016</year>) <volume>22</volume>(<issue>6</issue>):<fpage>598</fpage>.<pub-id pub-id-type="doi">10.1038/nm.4102</pub-id><?supplied-pmid 27158904?><pub-id pub-id-type="pmid">27158904</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moura-Alves</surname><given-names>P</given-names></name><name><surname>Fae</surname><given-names>K</given-names></name><name><surname>Houthuys</surname><given-names>E</given-names></name><name><surname>Dorhoi</surname><given-names>A</given-names></name><name><surname>Kreuchwig</surname><given-names>A</given-names></name><name><surname>Furkert</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>AhR sensing of bacterial pigments regulates antibacterial defence</article-title>. <source>Nature</source> (<year>2014</year>) <volume>512</volume>(<issue>7515</issue>):<fpage>387</fpage>&#8211;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1038/nature13684</pub-id><?supplied-pmid 25119038?><pub-id pub-id-type="pmid">25119038</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldhoen</surname><given-names>M</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Westendorf</surname><given-names>AM</given-names></name><name><surname>Buer</surname><given-names>J</given-names></name><name><surname>Dumoutier</surname><given-names>L</given-names></name><name><surname>Renauld</surname><given-names>JC</given-names></name><etal/></person-group>
<article-title>The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins</article-title>. <source>Nature</source> (<year>2008</year>) <volume>453</volume>(<issue>7191</issue>):<fpage>106</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nature06881</pub-id><?supplied-pmid 18362914?><pub-id pub-id-type="pmid">18362914</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>B</given-names></name><name><surname>Hirota</surname><given-names>K</given-names></name><name><surname>Cua</surname><given-names>DJ</given-names></name><name><surname>Stockinger</surname><given-names>B</given-names></name><name><surname>Veldhoen</surname><given-names>M</given-names></name></person-group>. <article-title>Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>31</volume>(<issue>2</issue>):<fpage>321</fpage>&#8211;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2009.06.020</pub-id><?supplied-pmid 19682928?><pub-id pub-id-type="pmid">19682928</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaidyanathan</surname><given-names>B</given-names></name><name><surname>Chaudhry</surname><given-names>A</given-names></name><name><surname>Yewdell</surname><given-names>WT</given-names></name><name><surname>Angeletti</surname><given-names>D</given-names></name><name><surname>Yen</surname><given-names>WF</given-names></name><name><surname>Wheatley</surname><given-names>AK</given-names></name><etal/></person-group>
<article-title>The aryl hydrocarbon receptor controls cell-fate decisions in B cells</article-title>. <source>J Exp Med</source> (<year>2017</year>) <volume>214</volume>(<issue>1</issue>):<fpage>197</fpage>&#8211;<lpage>208</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20160789</pub-id><?supplied-pmid 28011866?><pub-id pub-id-type="pmid">28011866</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villa</surname><given-names>M</given-names></name><name><surname>Gialitakis</surname><given-names>M</given-names></name><name><surname>Tolaini</surname><given-names>M</given-names></name><name><surname>Ahlfors</surname><given-names>H</given-names></name><name><surname>Henderson</surname><given-names>CJ</given-names></name><name><surname>Wolf</surname><given-names>CR</given-names></name><etal/></person-group>
<article-title>Aryl hydrocarbon receptor is required for optimal B-cell proliferation</article-title>. <source>EMBO J</source> (<year>2017</year>) <volume>36</volume>(<issue>1</issue>):<fpage>116</fpage>&#8211;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.15252/embj.201695027</pub-id><?supplied-pmid 27875245?><pub-id pub-id-type="pmid">27875245</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platzer</surname><given-names>B</given-names></name><name><surname>Richter</surname><given-names>S</given-names></name><name><surname>Kneidinger</surname><given-names>D</given-names></name><name><surname>Waltenberger</surname><given-names>D</given-names></name><name><surname>Woisetschlager</surname><given-names>M</given-names></name><name><surname>Strobl</surname><given-names>H</given-names></name></person-group>. <article-title>Aryl hydrocarbon receptor activation inhibits in vitro differentiation of human monocytes and Langerhans dendritic cells</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>183</volume>(<issue>1</issue>):<fpage>66</fpage>&#8211;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0802997</pub-id><?supplied-pmid 19535631?><pub-id pub-id-type="pmid">19535631</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>NT</given-names></name><name><surname>Kimura</surname><given-names>A</given-names></name><name><surname>Nakahama</surname><given-names>T</given-names></name><name><surname>Chinen</surname><given-names>I</given-names></name><name><surname>Masuda</surname><given-names>K</given-names></name><name><surname>Nohara</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>(<issue>46</issue>):<fpage>19961</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1014465107</pub-id><?supplied-pmid 21041655?><pub-id pub-id-type="pmid">21041655</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Innocentin</surname><given-names>S</given-names></name><name><surname>Withers</surname><given-names>DR</given-names></name><name><surname>Roberts</surname><given-names>NA</given-names></name><name><surname>Gallagher</surname><given-names>AR</given-names></name><name><surname>Grigorieva</surname><given-names>EF</given-names></name><etal/></person-group>
<article-title>Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation</article-title>. <source>Cell</source> (<year>2011</year>) <volume>147</volume>(<issue>3</issue>):<fpage>629</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2011.09.025</pub-id><?supplied-pmid 21999944?><pub-id pub-id-type="pmid">21999944</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinette</surname><given-names>ML</given-names></name><name><surname>Fuchs</surname><given-names>A</given-names></name><name><surname>Cortez</surname><given-names>VS</given-names></name><name><surname>Lee</surname><given-names>JS</given-names></name><name><surname>Wang</surname><given-names>YM</given-names></name><name><surname>Durum</surname><given-names>SK</given-names></name><etal/></person-group>
<article-title>Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets</article-title>. <source>Nat Immunol</source> (<year>2015</year>) <volume>16</volume>(<issue>3</issue>):<fpage>306</fpage>&#8211;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3094</pub-id><?supplied-pmid 25621825?><pub-id pub-id-type="pmid">25621825</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagage</surname><given-names>S</given-names></name><name><surname>John</surname><given-names>B</given-names></name><name><surname>Krock</surname><given-names>BL</given-names></name><name><surname>Hall</surname><given-names>AO</given-names></name><name><surname>Randall</surname><given-names>LM</given-names></name><name><surname>Karp</surname><given-names>CL</given-names></name><etal/></person-group>
<article-title>The aryl hydrocarbon receptor promotes IL-10 production by NK cells</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>(<issue>4</issue>):<fpage>1661</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1300497</pub-id><?supplied-pmid 24403534?><pub-id pub-id-type="pmid">24403534</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>JH</given-names></name><name><surname>Zhang</surname><given-names>LH</given-names></name><name><surname>Murillo-Sauca</surname><given-names>O</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kohrt</surname><given-names>HEK</given-names></name><name><surname>Bui</surname><given-names>JD</given-names></name><etal/></person-group>
<article-title>Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2013</year>) <volume>110</volume>(<issue>30</issue>):<fpage>12391</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1302856110</pub-id><?supplied-pmid 23836658?><pub-id pub-id-type="pmid">23836658</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>JH</given-names></name><name><surname>Haggadone</surname><given-names>MD</given-names></name><name><surname>Sunwoo</surname><given-names>JB</given-names></name></person-group>. <article-title>Transcription factor Dlx3 induces aryl hydrocarbon receptor promoter activity</article-title>. <source>Biochem Biophys Rep</source> (<year>2016</year>) <volume>7</volume>:<fpage>353</fpage>&#8211;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbrep.2016.06.023</pub-id><?supplied-pmid 27777986?><pub-id pub-id-type="pmid">27777986</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>B</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Xiong</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>WASH maintains NKp46+ ILC3 cells by promoting AHR expression</article-title>. <source>Nat Commun</source> (<year>2017</year>) <volume>8</volume>:<fpage>15685</fpage>.<pub-id pub-id-type="doi">10.1038/ncomms15685</pub-id><?supplied-pmid 28589939?><pub-id pub-id-type="pmid">28589939</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiering</surname><given-names>C</given-names></name><name><surname>Wincent</surname><given-names>E</given-names></name><name><surname>Metidji</surname><given-names>A</given-names></name><name><surname>Iseppon</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Potocnik</surname><given-names>AJ</given-names></name><etal/></person-group>
<article-title>Feedback control of AHR signalling regulates intestinal immunity</article-title>. <source>Nature</source> (<year>2017</year>) <volume>542</volume>(<issue>7640</issue>):<fpage>242</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/nature21080</pub-id><?supplied-pmid 28146477?><pub-id pub-id-type="pmid">28146477</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>J</given-names></name><name><surname>Bostick</surname><given-names>JW</given-names></name><name><surname>Ueda</surname><given-names>A</given-names></name><name><surname>Schjerven</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>The aryl hydrocarbon receptor preferentially marks and promotes gut regulatory T cells</article-title>. <source>Cell Rep</source> (<year>2017</year>) <volume>21</volume>(<issue>8</issue>):<fpage>2277</fpage>&#8211;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1016/j.celrep.2017.10.114</pub-id><pub-id pub-id-type="pmid">29166616</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>LH</given-names></name><name><surname>Shin</surname><given-names>JH</given-names></name><name><surname>Haggadone</surname><given-names>MD</given-names></name><name><surname>Sunwoo</surname><given-names>JB</given-names></name></person-group>. <article-title>The aryl hydrocarbon receptor is required for the maintenance of liver-resident natural killer cells</article-title>. <source>J Exp Med</source> (<year>2016</year>) <volume>213</volume>(<issue>11</issue>):<fpage>2249</fpage>&#8211;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20151998</pub-id><?supplied-pmid 27670593?><pub-id pub-id-type="pmid">27670593</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duerr</surname><given-names>CU</given-names></name><name><surname>McCarthy</surname><given-names>CDA</given-names></name><name><surname>Mindt</surname><given-names>BC</given-names></name><name><surname>Rubio</surname><given-names>M</given-names></name><name><surname>Meli</surname><given-names>AP</given-names></name><name><surname>Pothlichet</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>1</issue>):<fpage>65</fpage><pub-id pub-id-type="doi">10.1038/ni.3308</pub-id><pub-id pub-id-type="pmid">26595887</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molofsky</surname><given-names>AB</given-names></name><name><surname>Van Gool</surname><given-names>F</given-names></name><name><surname>Liang</surname><given-names>HE</given-names></name><name><surname>Van Dyken</surname><given-names>SJ</given-names></name><name><surname>Nussbaum</surname><given-names>JC</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Interleukin-33 and interferon-gamma counter-regulate group 2 innate lymphoid cell activation during immune perturbation</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>43</volume>(<issue>1</issue>):<fpage>161</fpage>&#8211;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.05.019</pub-id><pub-id pub-id-type="pmid">26092469</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Badawy</surname><given-names>AA</given-names></name></person-group>. <article-title>Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects</article-title>. <source>Int J Tryptophan Res</source> (<year>2017</year>) <volume>10</volume>:<fpage>1178646917691938</fpage>.<pub-id pub-id-type="doi">10.1177/1178646917691938</pub-id><?supplied-pmid 28469468?><pub-id pub-id-type="pmid">28469468</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurgens</surname><given-names>B</given-names></name><name><surname>Hainz</surname><given-names>U</given-names></name><name><surname>Fuchs</surname><given-names>D</given-names></name><name><surname>Felzmann</surname><given-names>T</given-names></name><name><surname>Heitger</surname><given-names>A</given-names></name></person-group>. <article-title>Interferon-gamma-triggered indoleamine 2,3-dioxygenase competence in human monocyte-derived dendritic cells induces regulatory activity in allogeneic T cells</article-title>. <source>Blood</source> (<year>2009</year>) <volume>114</volume>(<issue>15</issue>):<fpage>3235</fpage>&#8211;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2008-12-195073</pub-id><?supplied-pmid 19625705?><pub-id pub-id-type="pmid">19625705</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Pappu</surname><given-names>R</given-names></name><name><surname>Ramirez-Carrozzi</surname><given-names>V</given-names></name><name><surname>Ota</surname><given-names>N</given-names></name><name><surname>Caplazi</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers</article-title>. <source>Mucosal Immunol</source> (<year>2014</year>) <volume>7</volume>(<issue>3</issue>):<fpage>730</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2013.92</pub-id><?supplied-pmid 24220298?><pub-id pub-id-type="pmid">24220298</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>AI</given-names></name><name><surname>Menegatti</surname><given-names>S</given-names></name><name><surname>Bustamante</surname><given-names>J</given-names></name><name><surname>Le Bourhis</surname><given-names>L</given-names></name><name><surname>Allez</surname><given-names>M</given-names></name><name><surname>Rogge</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>IL-12 drives functional plasticity of human group 2 innate lymphoid cells</article-title>. <source>J Exp Med</source> (<year>2016</year>) <volume>213</volume>(<issue>4</issue>):<fpage>569</fpage>&#8211;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20151750</pub-id><?supplied-pmid 26976630?><pub-id pub-id-type="pmid">26976630</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernink</surname><given-names>JH</given-names></name><name><surname>Peters</surname><given-names>CP</given-names></name><name><surname>Munneke</surname><given-names>M</given-names></name><name><surname>te Velde</surname><given-names>AA</given-names></name><name><surname>Meijer</surname><given-names>SL</given-names></name><name><surname>Weijer</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>(<issue>3</issue>):<fpage>221</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2534</pub-id><pub-id pub-id-type="pmid">23334791</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vonarbourg</surname><given-names>C</given-names></name><name><surname>Mortha</surname><given-names>A</given-names></name><name><surname>Bui</surname><given-names>VL</given-names></name><name><surname>Hernandez</surname><given-names>PP</given-names></name><name><surname>Kiss</surname><given-names>EA</given-names></name><name><surname>Hoyler</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes</article-title>. <source>Immunity</source> (<year>2010</year>) <volume>33</volume>(<issue>5</issue>):<fpage>736</fpage>&#8211;<lpage>51</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2010.10.017</pub-id><pub-id pub-id-type="pmid">21093318</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernink</surname><given-names>JH</given-names></name><name><surname>Krabbendam</surname><given-names>L</given-names></name><name><surname>Germar</surname><given-names>K</given-names></name><name><surname>de Jong</surname><given-names>E</given-names></name><name><surname>Gronke</surname><given-names>K</given-names></name><name><surname>Kofoed-Nielsen</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>43</volume>(<issue>1</issue>):<fpage>146</fpage>&#8211;<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.019</pub-id><?supplied-pmid 26187413?><pub-id pub-id-type="pmid">26187413</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>T</given-names></name><name><surname>Briercheck</surname><given-names>EL</given-names></name><name><surname>Freud</surname><given-names>AG</given-names></name><name><surname>Trotta</surname><given-names>R</given-names></name><name><surname>McClory</surname><given-names>S</given-names></name><name><surname>Scoville</surname><given-names>SD</given-names></name><etal/></person-group>
<article-title>The transcription factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells</article-title>. <source>Cell Rep</source> (<year>2014</year>) <volume>8</volume>(<issue>1</issue>):<fpage>150</fpage>&#8211;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.celrep.2014.05.042</pub-id><?supplied-pmid 24953655?><pub-id pub-id-type="pmid">24953655</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bal</surname><given-names>SM</given-names></name><name><surname>Bernink</surname><given-names>JH</given-names></name><name><surname>Nagasawa</surname><given-names>M</given-names></name><name><surname>Groot</surname><given-names>J</given-names></name><name><surname>Shikhagaie</surname><given-names>MM</given-names></name><name><surname>Golebski</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>IL-1 beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>6</issue>):<fpage>636</fpage><pub-id pub-id-type="doi">10.1038/ni.3444</pub-id><pub-id pub-id-type="pmid">27111145</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohne</surname><given-names>Y</given-names></name><name><surname>Silver</surname><given-names>JS</given-names></name><name><surname>Thompson-Snipes</surname><given-names>L</given-names></name><name><surname>Collet</surname><given-names>MA</given-names></name><name><surname>Blanck</surname><given-names>JP</given-names></name><name><surname>Cantarel</surname><given-names>BL</given-names></name><etal/></person-group>
<article-title>IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity (vol 17, pg 646, 2016)</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>8</issue>):<fpage>1005</fpage><pub-id pub-id-type="doi">10.1038/ni.3447</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silver</surname><given-names>JS</given-names></name><name><surname>Kearley</surname><given-names>J</given-names></name><name><surname>Copenhaver</surname><given-names>AM</given-names></name><name><surname>Sanden</surname><given-names>C</given-names></name><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs (vol 17, pg 626, 2016)</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>8</issue>):<fpage>1005</fpage><pub-id pub-id-type="doi">10.1038/ni.3443</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longman</surname><given-names>RS</given-names></name><name><surname>Diehl</surname><given-names>GE</given-names></name><name><surname>Victorio</surname><given-names>DA</given-names></name><name><surname>Huh</surname><given-names>JR</given-names></name><name><surname>Galan</surname><given-names>C</given-names></name><name><surname>Miraldi</surname><given-names>ER</given-names></name><etal/></person-group>
<article-title>CX(3)CR1(+) mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22</article-title>. <source>J Exp Med</source> (<year>2014</year>) <volume>211</volume>(<issue>8</issue>):<fpage>1571</fpage>&#8211;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20140678</pub-id><pub-id pub-id-type="pmid">25024136</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mielke</surname><given-names>LA</given-names></name><name><surname>Jones</surname><given-names>SA</given-names></name><name><surname>Raverdeau</surname><given-names>M</given-names></name><name><surname>Higgs</surname><given-names>R</given-names></name><name><surname>Stefanska</surname><given-names>A</given-names></name><name><surname>Groom</surname><given-names>JR</given-names></name><etal/></person-group>
<article-title>Retinoic acid expression associates with enhanced IL-22 production by gammadelta T cells and innate lymphoid cells and attenuation of intestinal inflammation</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>(<issue>6</issue>):<fpage>1117</fpage>&#8211;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20121588</pub-id><pub-id pub-id-type="pmid">23690441</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satoh-Takayama</surname><given-names>N</given-names></name><name><surname>Serafini</surname><given-names>N</given-names></name><name><surname>Verrier</surname><given-names>T</given-names></name><name><surname>Rekiki</surname><given-names>A</given-names></name><name><surname>Renauld</surname><given-names>JC</given-names></name><name><surname>Frankel</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>The chemokine receptor CXCR6 controls the functional topography of interleukin-22 producing intestinal innate lymphoid cells</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>41</volume>(<issue>5</issue>):<fpage>776</fpage>&#8211;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.10.007</pub-id><?supplied-pmid 25456160?><pub-id pub-id-type="pmid">25456160</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boitano</surname><given-names>AE</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Romeo</surname><given-names>R</given-names></name><name><surname>Bouchez</surname><given-names>LC</given-names></name><name><surname>Parker</surname><given-names>AE</given-names></name><name><surname>Sutton</surname><given-names>SE</given-names></name><etal/></person-group>
<article-title>Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells</article-title>. <source>Science</source> (<year>2010</year>) <volume>329</volume>(<issue>5997</issue>):<fpage>1345</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1126/science.1191536</pub-id><?supplied-pmid 20688981?><pub-id pub-id-type="pmid">20688981</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thordardottir</surname><given-names>S</given-names></name><name><surname>Hangalapura</surname><given-names>BN</given-names></name><name><surname>Hutten</surname><given-names>T</given-names></name><name><surname>Cossu</surname><given-names>M</given-names></name><name><surname>Spanholtz</surname><given-names>J</given-names></name><name><surname>Schaap</surname><given-names>N</given-names></name><etal/></person-group>
<article-title>The aryl hydrocarbon receptor antagonist StemRegenin 1 promotes human plasmacytoid and myeloid dendritic cell development from CD34+ hematopoietic progenitor cells</article-title>. <source>Stem Cells Dev</source> (<year>2014</year>) <volume>23</volume>(<issue>9</issue>):<fpage>955</fpage>&#8211;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1089/scd.2013.0521</pub-id><?supplied-pmid 24325394?><pub-id pub-id-type="pmid">24325394</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bankoti</surname><given-names>J</given-names></name><name><surname>Rase</surname><given-names>B</given-names></name><name><surname>Simones</surname><given-names>T</given-names></name><name><surname>Shepherd</surname><given-names>DM</given-names></name></person-group>. <article-title>Functional and phenotypic effects of AhR activation in inflammatory dendritic cells</article-title>. <source>Toxicol Appl Pharmacol</source> (<year>2010</year>) <volume>246</volume>(<issue>1&#8211;2</issue>):<fpage>18</fpage>&#8211;<lpage>28</lpage>.<pub-id pub-id-type="doi">10.1016/j.taap.2010.03.013</pub-id><?supplied-pmid 20350561?><pub-id pub-id-type="pmid">20350561</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintana</surname><given-names>FJ</given-names></name><name><surname>Murugaiyan</surname><given-names>G</given-names></name><name><surname>Farez</surname><given-names>MF</given-names></name><name><surname>Mitsdoerffer</surname><given-names>M</given-names></name><name><surname>Tukpah</surname><given-names>AM</given-names></name><name><surname>Burns</surname><given-names>EJ</given-names></name><etal/></person-group>
<article-title>An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>(<issue>48</issue>):<fpage>20768</fpage>&#8211;<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1009201107</pub-id><?supplied-pmid 21068375?><pub-id pub-id-type="pmid">21068375</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goudot</surname><given-names>C</given-names></name><name><surname>Coillard</surname><given-names>A</given-names></name><name><surname>Villani</surname><given-names>AC</given-names></name><name><surname>Gueguen</surname><given-names>P</given-names></name><name><surname>Cros</surname><given-names>A</given-names></name><name><surname>Sarkizova</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Aryl hydrocarbon receptor controls monocyte differentiation into dendritic cells versus macrophages</article-title>. <source>Immunity</source> (<year>2017</year>) <volume>47</volume>(<issue>3</issue>):<fpage>582</fpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.08.016</pub-id><pub-id pub-id-type="pmid">28930664</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flannigan</surname><given-names>KL</given-names></name><name><surname>Ngo</surname><given-names>VL</given-names></name><name><surname>Geem</surname><given-names>D</given-names></name><name><surname>Harusato</surname><given-names>A</given-names></name><name><surname>Hirota</surname><given-names>SA</given-names></name><name><surname>Parkos</surname><given-names>CA</given-names></name><etal/></person-group>
<article-title>IL-17A-mediated neutrophil recruitment limits expansion of segmented filamentous bacteria</article-title>. <source>Mucosal Immunol</source> (<year>2017</year>) <volume>10</volume>(<issue>3</issue>):<fpage>673</fpage>&#8211;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2016.80</pub-id><?supplied-pmid 27624780?><pub-id pub-id-type="pmid">27624780</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>JW</given-names></name><name><surname>Sokol</surname><given-names>CL</given-names></name><name><surname>Luster</surname><given-names>AD</given-names></name></person-group>. <article-title>Chemokines and chemokine receptors: positioning cells for host defense and immunity</article-title>. <source>Annu Rev Immunol</source> (<year>2014</year>) <volume>32</volume>:<fpage>659</fpage>&#8211;<lpage>702</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120145</pub-id><?supplied-pmid 24655300?><pub-id pub-id-type="pmid">24655300</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shih</surname><given-names>VFS</given-names></name><name><surname>Cox</surname><given-names>J</given-names></name><name><surname>Kljavin</surname><given-names>NM</given-names></name><name><surname>Dengler</surname><given-names>HS</given-names></name><name><surname>Reichelt</surname><given-names>M</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Homeostatic IL-23 receptor signaling limits Th17 response through IL-22-mediated containment of commensal microbiota</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2014</year>) <volume>111</volume>(<issue>38</issue>):<fpage>13942</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1323852111</pub-id><?supplied-pmid 25201978?><pub-id pub-id-type="pmid">25201978</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>II</given-names></name><name><surname>Atarashi</surname><given-names>K</given-names></name><name><surname>Manel</surname><given-names>N</given-names></name><name><surname>Brodie</surname><given-names>EL</given-names></name><name><surname>Shima</surname><given-names>T</given-names></name><name><surname>Karaoz</surname><given-names>U</given-names></name><etal/></person-group>
<article-title>Induction of intestinal Th17 cells by segmented filamentous bacteria</article-title>. <source>Cell</source> (<year>2009</year>) <volume>139</volume>(<issue>3</issue>):<fpage>485</fpage>&#8211;<lpage>98</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2009.09.033</pub-id><?supplied-pmid 19836068?><pub-id pub-id-type="pmid">19836068</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Panea</surname><given-names>C</given-names></name><name><surname>Nakato</surname><given-names>G</given-names></name><name><surname>Cebula</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Diez</surname><given-names>MG</given-names></name><etal/></person-group>
<article-title>Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>40</volume>(<issue>4</issue>):<fpage>594</fpage>&#8211;<lpage>607</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.03.005</pub-id><?supplied-pmid 24684957?><pub-id pub-id-type="pmid">24684957</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>T</given-names></name><name><surname>Huang</surname><given-names>WD</given-names></name><name><surname>Hall</surname><given-names>JA</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>Gavzy</surname><given-names>SJ</given-names></name><etal/></person-group>
<article-title>An IL-23R/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses</article-title>. <source>Cell</source> (<year>2015</year>) <volume>163</volume>(<issue>2</issue>):<fpage>381</fpage>&#8211;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2015.08.061</pub-id><?supplied-pmid 26411290?><pub-id pub-id-type="pmid">26411290</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atarashi</surname><given-names>K</given-names></name><name><surname>Tanoue</surname><given-names>T</given-names></name><name><surname>Ando</surname><given-names>M</given-names></name><name><surname>Kamada</surname><given-names>N</given-names></name><name><surname>Nagano</surname><given-names>Y</given-names></name><name><surname>Narushima</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Th17 cell induction by adhesion of microbes to intestinal epithelial cells</article-title>. <source>Cell</source> (<year>2015</year>) <volume>163</volume>(<issue>2</issue>):<fpage>367</fpage>&#8211;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2015.08.058</pub-id><?supplied-pmid 26411289?><pub-id pub-id-type="pmid">26411289</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pabst</surname><given-names>O</given-names></name><name><surname>Herbrand</surname><given-names>H</given-names></name><name><surname>Worbs</surname><given-names>T</given-names></name><name><surname>Friedrichsen</surname><given-names>M</given-names></name><name><surname>Yan</surname><given-names>S</given-names></name><name><surname>Hoffmann</surname><given-names>MW</given-names></name><etal/></person-group>
<article-title>Cryptopatches and isolated lymphoid follicles: dynamic lymphoid tissues dispensable for the generation of intraepithelial lymphocytes</article-title>. <source>Eur J Immunol</source> (<year>2005</year>) <volume>35</volume>(<issue>1</issue>):<fpage>98</fpage>&#8211;<lpage>107</lpage>.<pub-id pub-id-type="doi">10.1002/eji.200425432</pub-id><?supplied-pmid 15580658?><pub-id pub-id-type="pmid">15580658</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuji</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Kitamura</surname><given-names>H</given-names></name><name><surname>Maruya</surname><given-names>M</given-names></name><name><surname>Kinoshita</surname><given-names>K</given-names></name><name><surname>Ivanov</surname><given-names>II</given-names></name><etal/></person-group>
<article-title>Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>29</volume>(<issue>2</issue>):<fpage>261</fpage>&#8211;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2008.05.014</pub-id><?supplied-pmid 18656387?><pub-id pub-id-type="pmid">18656387</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Bhattacharya</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Phadnis-Moghe</surname><given-names>AS</given-names></name><name><surname>Crawford</surname><given-names>RB</given-names></name><name><surname>Kaminski</surname><given-names>NE</given-names></name></person-group>
<article-title>Aryl hydrocarbon receptor activation suppresses EBF1 and PAX5 and impairs human B lymphopoiesis</article-title>. <source>J Immunol</source> (<year>2017</year>) <volume>199</volume>(<issue>10</issue>):<fpage>3504</fpage>&#8211;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1700289</pub-id><pub-id pub-id-type="pmid">28978690</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halim</surname><given-names>TY</given-names></name><name><surname>Hwang</surname><given-names>YY</given-names></name><name><surname>Scanlon</surname><given-names>ST</given-names></name><name><surname>Zaghouani</surname><given-names>H</given-names></name><name><surname>Garbi</surname><given-names>N</given-names></name><name><surname>Fallon</surname><given-names>PG</given-names></name><etal/></person-group>
<article-title>Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>1</issue>):<fpage>57</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3294</pub-id><?supplied-pmid 26523868?><pub-id pub-id-type="pmid">26523868</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz</surname><given-names>C</given-names></name><name><surname>Khan</surname><given-names>AR</given-names></name><name><surname>Floudas</surname><given-names>A</given-names></name><name><surname>Saunders</surname><given-names>SP</given-names></name><name><surname>Hams</surname><given-names>E</given-names></name><name><surname>Rodewald</surname><given-names>HR</given-names></name><etal/></person-group>
<article-title>ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control</article-title>. <source>J Exp Med</source> (<year>2017</year>) <volume>214</volume>(<issue>9</issue>):<fpage>2507</fpage>&#8211;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20170051</pub-id><?supplied-pmid 28747424?><pub-id pub-id-type="pmid">28747424</pub-id></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauber</surname><given-names>S</given-names></name><name><surname>Luber</surname><given-names>M</given-names></name><name><surname>Weber</surname><given-names>S</given-names></name><name><surname>Maul</surname><given-names>L</given-names></name><name><surname>Soare</surname><given-names>A</given-names></name><name><surname>Wohlfahrt</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells</article-title>. <source>Nat Med</source> (<year>2017</year>) <volume>23</volume>(<issue>8</issue>):<fpage>938</fpage>&#8211;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1038/nm.4373</pub-id><?supplied-pmid 28714991?><pub-id pub-id-type="pmid">28714991</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>CE</given-names></name><name><surname>Spasova</surname><given-names>DS</given-names></name><name><surname>Frimpong-Boateng</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>HO</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><etal/></person-group>
<article-title>Interleukin-7 availability is maintained by a hematopoietic cytokine sink comprising innate lymphoid cells and T cells</article-title>. <source>Immunity</source> (<year>2017</year>) <volume>47</volume>(<issue>1</issue>):<fpage>171</fpage><pub-id pub-id-type="doi">10.1016/j.immuni.2017.07.005</pub-id><pub-id pub-id-type="pmid">28723549</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliphant</surname><given-names>CJ</given-names></name><name><surname>Hwang</surname><given-names>YY</given-names></name><name><surname>Walker</surname><given-names>JA</given-names></name><name><surname>Salimi</surname><given-names>M</given-names></name><name><surname>Wong</surname><given-names>SH</given-names></name><name><surname>Brewer</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 Immunity and promotes parasitic helminth expulsion</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>41</volume>(<issue>2</issue>):<fpage>283</fpage>&#8211;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.016</pub-id><?supplied-pmid 25088770?><pub-id pub-id-type="pmid">25088770</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hepworth</surname><given-names>MR</given-names></name><name><surname>Monticelli</surname><given-names>LA</given-names></name><name><surname>Fung</surname><given-names>TC</given-names></name><name><surname>Ziegler</surname><given-names>CGK</given-names></name><name><surname>Grunberg</surname><given-names>S</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Innate lymphoid cells regulate CD4(+) T-cell responses to intestinal commensal bacteria</article-title>. <source>Nature</source> (<year>2013</year>) <volume>498</volume>(<issue>7452</issue>):<fpage>113</fpage><pub-id pub-id-type="doi">10.1038/nature12240</pub-id><pub-id pub-id-type="pmid">23698371</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hepworth</surname><given-names>MR</given-names></name><name><surname>Fung</surname><given-names>TC</given-names></name><name><surname>Masur</surname><given-names>SH</given-names></name><name><surname>Kelsen</surname><given-names>JR</given-names></name><name><surname>McConnell</surname><given-names>FM</given-names></name><name><surname>Dubrot</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells</article-title>. <source>Science</source> (<year>2015</year>) <volume>348</volume>(<issue>6238</issue>):<fpage>1031</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1126/science.aaa4812</pub-id><pub-id pub-id-type="pmid">25908663</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>MY</given-names></name><name><surname>Gaspal</surname><given-names>FMC</given-names></name><name><surname>Wiggett</surname><given-names>HE</given-names></name><name><surname>McConnell</surname><given-names>FM</given-names></name><name><surname>Gulbranson-Judge</surname><given-names>A</given-names></name><name><surname>Raykundalia</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells</article-title>. <source>Immunity</source> (<year>2003</year>) <volume>18</volume>(<issue>5</issue>):<fpage>643</fpage>&#8211;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(03)00110-9</pub-id><?supplied-pmid 12753741?><pub-id pub-id-type="pmid">12753741</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwong</surname><given-names>B</given-names></name><name><surname>Rua</surname><given-names>R</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Flickinger</surname><given-names>J</given-names><suffix>Jr</suffix></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kruhlak</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation</article-title>. <source>Nat Immunol</source> (<year>2017</year>) <volume>18</volume>(<issue>10</issue>):<fpage>1117</fpage>&#8211;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1038/ni.3816</pub-id><?supplied-pmid 28805812?><pub-id pub-id-type="pmid">28805812</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>Y</given-names></name><name><surname>Obata</surname><given-names>T</given-names></name><name><surname>Kunisawa</surname><given-names>J</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Ivanov</surname><given-names>II</given-names></name><name><surname>Lamichhane</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Innate lymphoid cells regulate intestinal epithelial cell glycosylation</article-title>. <source>Science</source> (<year>2014</year>) <volume>345</volume>(<issue>6202</issue>):<fpage>1310</fpage>.<pub-id pub-id-type="doi">10.1126/Science.1254009</pub-id><?supplied-pmid 25214634?><pub-id pub-id-type="pmid">25214634</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindemans</surname><given-names>CA</given-names></name><name><surname>Calafiore</surname><given-names>M</given-names></name><name><surname>Mertelsmann</surname><given-names>AM</given-names></name><name><surname>O&#8217;Connor</surname><given-names>MH</given-names></name><name><surname>Dudakov</surname><given-names>JA</given-names></name><name><surname>Jenq</surname><given-names>RR</given-names></name><etal/></person-group>
<article-title>Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration</article-title>. <source>Nature</source> (<year>2015</year>) <volume>528</volume>(<issue>7583</issue>):<fpage>560</fpage>&#8211;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1038/nature16460</pub-id><?supplied-pmid 26649819?><pub-id pub-id-type="pmid">26649819</pub-id></mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aparicio-Domingo</surname><given-names>P</given-names></name><name><surname>Romera-Hernandez</surname><given-names>M</given-names></name><name><surname>Karrich</surname><given-names>JJ</given-names></name><name><surname>Cornelissen</surname><given-names>F</given-names></name><name><surname>Papazian</surname><given-names>N</given-names></name><name><surname>Lindenbergh-Kortleve</surname><given-names>DJ</given-names></name><etal/></person-group>
<article-title>Type 3 innate lymphoid cells maintain intestinal epithelial stem cells after tissue damage</article-title>. <source>J Exp Med</source> (<year>2015</year>) <volume>212</volume>(<issue>11</issue>):<fpage>1783</fpage>&#8211;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20150318</pub-id><?supplied-pmid 26392223?><pub-id pub-id-type="pmid">26392223</pub-id></mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gury-BenAri</surname><given-names>M</given-names></name><name><surname>Thaiss</surname><given-names>CA</given-names></name><name><surname>Serafini</surname><given-names>N</given-names></name><name><surname>Winter</surname><given-names>DR</given-names></name><name><surname>Giladi</surname><given-names>A</given-names></name><name><surname>Lara-Astiaso</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome</article-title>. <source>Cell</source> (<year>2016</year>) <volume>166</volume>(<issue>5</issue>):<fpage>1231</fpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2016.07.043</pub-id><?supplied-pmid 27545347?><pub-id pub-id-type="pmid">27545347</pub-id></mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ibiza</surname><given-names>S</given-names></name><name><surname>Garcia-Cassani</surname><given-names>B</given-names></name><name><surname>Ribeiro</surname><given-names>H</given-names></name><name><surname>Carvalho</surname><given-names>T</given-names></name><name><surname>Almeida</surname><given-names>L</given-names></name><name><surname>Marques</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence</article-title>. <source>Nature</source> (<year>2016</year>) <volume>535</volume>(<issue>7612</issue>):<fpage>440</fpage>&#8211;<lpage>3</lpage>.<pub-id pub-id-type="doi">10.1038/nature18644</pub-id><?supplied-pmid 27409807?><pub-id pub-id-type="pmid">27409807</pub-id></mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klose</surname><given-names>CSN</given-names></name><name><surname>Mahlakoiv</surname><given-names>T</given-names></name><name><surname>Moeller</surname><given-names>JB</given-names></name><name><surname>Rankin</surname><given-names>LC</given-names></name><name><surname>Flamar</surname><given-names>AL</given-names></name><name><surname>Kabata</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation</article-title>. <source>Nature</source> (<year>2017</year>) <volume>549</volume>:<fpage>282</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/nature23676</pub-id><pub-id pub-id-type="pmid">28869965</pub-id></mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cardoso</surname><given-names>V</given-names></name><name><surname>Chesne</surname><given-names>J</given-names></name><name><surname>Ribeiro</surname><given-names>H</given-names></name><name><surname>Garcia-Cassani</surname><given-names>B</given-names></name><name><surname>Carvalho</surname><given-names>T</given-names></name><name><surname>Bouchery</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Neuronal regulation of type 2 innate lymphoid cells via neuromedin U</article-title>. <source>Nature</source> (<year>2017</year>) <volume>549</volume>(<issue>7671</issue>):<fpage>277</fpage>&#8211;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1038/nature23469</pub-id><?supplied-pmid 28869974?><pub-id pub-id-type="pmid">28869974</pub-id></mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallrapp</surname><given-names>A</given-names></name><name><surname>Riesenfeld</surname><given-names>SJ</given-names></name><name><surname>Burkett</surname><given-names>PR</given-names></name><name><surname>Abdulnour</surname><given-names>RE</given-names></name><name><surname>Nyman</surname><given-names>J</given-names></name><name><surname>Dionne</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation</article-title>. <source>Nature</source> (<year>2017</year>) <volume>549</volume>(<issue>7672</issue>):<fpage>351</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/nature24029</pub-id><?supplied-pmid 28902842?><pub-id pub-id-type="pmid">28902842</pub-id></mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Heller</surname><given-names>JJ</given-names></name><name><surname>Bostick</surname><given-names>JW</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Schjerven</surname><given-names>H</given-names></name><name><surname>Kastner</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Ikaros inhibits group 3 innate lymphoid cell development and function by suppressing the aryl hydrocarbon receptor pathway</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>45</volume>(<issue>1</issue>):<fpage>185</fpage>&#8211;<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2016.06.027</pub-id><?supplied-pmid 27438771?><pub-id pub-id-type="pmid">27438771</pub-id></mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutz</surname><given-names>S</given-names></name><name><surname>Noubade</surname><given-names>R</given-names></name><name><surname>Eidenschenk</surname><given-names>C</given-names></name><name><surname>Ota</surname><given-names>N</given-names></name><name><surname>Zeng</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Transcription factor c-Maf mediates the TGF-beta-dependent suppression of IL-22 production in T(H)17 cells</article-title>. <source>Nat Immunol</source> (<year>2011</year>) <volume>12</volume>(<issue>12</issue>):<fpage>1238</fpage>&#8211;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1038/ni.2134</pub-id><pub-id pub-id-type="pmid">22001828</pub-id></mixed-citation></ref><ref id="B159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apetoh</surname><given-names>L</given-names></name><name><surname>Quintana</surname><given-names>FJ</given-names></name><name><surname>Pot</surname><given-names>C</given-names></name><name><surname>Joller</surname><given-names>N</given-names></name><name><surname>Xiao</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>(<issue>9</issue>):<fpage>854</fpage>&#8211;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1038/ni.1912</pub-id><?supplied-pmid 20676095?><pub-id pub-id-type="pmid">20676095</pub-id></mixed-citation></ref><ref id="B160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogel</surname><given-names>CF</given-names></name><name><surname>Sciullo</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Wong</surname><given-names>P</given-names></name><name><surname>Lazennec</surname><given-names>G</given-names></name><name><surname>Matsumura</surname><given-names>F</given-names></name></person-group>. <article-title>RelB, a new partner of aryl hydrocarbon receptor-mediated transcription</article-title>. <source>Mol Endocrinol</source> (<year>2007</year>) <volume>21</volume>(<issue>12</issue>):<fpage>2941</fpage>&#8211;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1210/me.2007-0211</pub-id><?supplied-pmid 17823304?><pub-id pub-id-type="pmid">17823304</pub-id></mixed-citation></ref><ref id="B161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogel</surname><given-names>CF</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Goth</surname><given-names>SR</given-names></name><name><surname>Baek</surname><given-names>J</given-names></name><name><surname>Lollies</surname><given-names>A</given-names></name><name><surname>Domhardt</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Aryl hydrocarbon receptor signaling regulates NF-kappaB RelB activation during dendritic-cell differentiation</article-title>. <source>Immunol Cell Biol</source> (<year>2013</year>) <volume>91</volume>(<issue>9</issue>):<fpage>568</fpage>&#8211;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1038/icb.2013.43</pub-id><pub-id pub-id-type="pmid">23999131</pub-id></mixed-citation></ref><ref id="B162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>PH</given-names></name><name><surname>Chang</surname><given-names>H</given-names></name><name><surname>Chang</surname><given-names>JT</given-names></name><name><surname>Lin</surname><given-names>P</given-names></name></person-group>. <article-title>Aryl hydrocarbon receptor in association with RelA modulates IL-6 expression in non-smoking lung cancer</article-title>. <source>Oncogene</source> (<year>2012</year>) <volume>31</volume>(<issue>20</issue>):<fpage>2555</fpage>&#8211;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1038/onc.2011.438</pub-id><?supplied-pmid 21996739?><pub-id pub-id-type="pmid">21996739</pub-id></mixed-citation></ref><ref id="B163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohtake</surname><given-names>F</given-names></name><name><surname>Baba</surname><given-names>A</given-names></name><name><surname>Takada</surname><given-names>I</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Iwasaki</surname><given-names>K</given-names></name><name><surname>Miki</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Dioxin receptor is a ligand-dependent E3 ubiquitin ligase</article-title>. <source>Nature</source> (<year>2007</year>) <volume>446</volume>(<issue>7135</issue>):<fpage>562</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1038/nature05683</pub-id><?supplied-pmid 17392787?><pub-id pub-id-type="pmid">17392787</pub-id></mixed-citation></ref><ref id="B164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luecke-Johansson</surname><given-names>S</given-names></name><name><surname>Gralla</surname><given-names>M</given-names></name><name><surname>Rundqvist</surname><given-names>H</given-names></name><name><surname>Ho</surname><given-names>JC</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name><name><surname>Gradin</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>A molecular mechanism to switch the aryl hydrocarbon receptor from a transcription factor to an E3 ubiquitin ligase</article-title>. <source>Mol Cell Biol</source> (<year>2017</year>) <volume>37</volume>(<issue>13</issue>).<pub-id pub-id-type="doi">10.1128/MCB.00630-16</pub-id><?supplied-pmid 28416634?><pub-id pub-id-type="pmid">28416634</pub-id></mixed-citation></ref><ref id="B165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaeger</surname><given-names>C</given-names></name><name><surname>Tischkau</surname><given-names>SA</given-names></name></person-group>. <article-title>Role of aryl hydrocarbon receptor in circadian clock disruption and metabolic dysfunction</article-title>. <source>Environ Health Insights</source> (<year>2016</year>) <volume>10</volume>:<fpage>133</fpage>&#8211;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.4137/EHI.S38343</pub-id><?supplied-pmid 27559298?><pub-id pub-id-type="pmid">27559298</pub-id></mixed-citation></ref><ref id="B166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tischkau</surname><given-names>SA</given-names></name><name><surname>Jaeger</surname><given-names>CD</given-names></name><name><surname>Krager</surname><given-names>SL</given-names></name></person-group>. <article-title>Circadian clock disruption in the mouse ovary in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin</article-title>. <source>Toxicol Lett</source> (<year>2011</year>) <volume>201</volume>(<issue>2</issue>):<fpage>116</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1016/j.toxlet.2010.12.013</pub-id><?supplied-pmid 21182907?><pub-id pub-id-type="pmid">21182907</pub-id></mixed-citation></ref><ref id="B167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>CX</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Krager</surname><given-names>SL</given-names></name><name><surname>Bottum</surname><given-names>KM</given-names></name><name><surname>Tischkau</surname><given-names>SA</given-names></name></person-group>. <article-title>Aryl hydrocarbon receptor activation attenuates Per1 gene induction and influences circadian clock resetting</article-title>. <source>Toxicol Sci</source> (<year>2013</year>) <volume>132</volume>(<issue>2</issue>):<fpage>368</fpage>&#8211;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1093/toxsci/kfs345</pub-id><?supplied-pmid 23291558?><pub-id pub-id-type="pmid">23291558</pub-id></mixed-citation></ref><ref id="B168"><label>168</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>CX</given-names></name><name><surname>Krager</surname><given-names>SL</given-names></name><name><surname>Liao</surname><given-names>DF</given-names></name><name><surname>Tischkau</surname><given-names>SA</given-names></name></person-group>. <article-title>Disruption of CLOCK-BMAL1 transcriptional activity is responsible for aryl hydrocarbon receptor-mediated regulation of period1 gene</article-title>. <source>Toxicol Sci</source> (<year>2010</year>) <volume>115</volume>(<issue>1</issue>):<fpage>98</fpage>&#8211;<lpage>108</lpage>.<pub-id pub-id-type="doi">10.1093/toxsci/kfq022</pub-id><?supplied-pmid 20106950?><pub-id pub-id-type="pmid">20106950</pub-id></mixed-citation></ref><ref id="B169"><label>169</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takayama</surname><given-names>T</given-names></name><name><surname>Kamada</surname><given-names>N</given-names></name><name><surname>Chinen</surname><given-names>H</given-names></name><name><surname>Okamoto</surname><given-names>S</given-names></name><name><surname>Kitazume</surname><given-names>MT</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn&#8217;s disease</article-title>. <source>Gastroenterology</source> (<year>2010</year>) <volume>139</volume>(<issue>3</issue>):<fpage>882</fpage>&#8211;<lpage>92, 892.e1&#8211;3</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2010.05.040</pub-id><pub-id pub-id-type="pmid">20638936</pub-id></mixed-citation></ref><ref id="B170"><label>170</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizuno</surname><given-names>S</given-names></name><name><surname>Mikami</surname><given-names>Y</given-names></name><name><surname>Kamada</surname><given-names>N</given-names></name><name><surname>Handa</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Cross-talk between RORgammat+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn&#8217;s disease</article-title>. <source>Inflamm Bowel Dis</source> (<year>2014</year>) <volume>20</volume>(<issue>8</issue>):<fpage>1426</fpage>&#8211;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1097/MIB.0000000000000105</pub-id><pub-id pub-id-type="pmid">24991784</pub-id></mixed-citation></ref><ref id="B171"><label>171</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutz</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Ouyang</surname><given-names>W</given-names></name></person-group>
<article-title>The IL-20 subfamily of cytokines &#8211; from host defence to tissue homeostasis</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>(<issue>12</issue>):<fpage>783</fpage>&#8211;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1038/nri3766</pub-id><pub-id pub-id-type="pmid">25421700</pub-id></mixed-citation></ref><ref id="B172"><label>172</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geremia</surname><given-names>A</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>CV</given-names></name><name><surname>Fleming</surname><given-names>MP</given-names></name><name><surname>Rust</surname><given-names>N</given-names></name><name><surname>Singh</surname><given-names>B</given-names></name><name><surname>Mortensen</surname><given-names>NJ</given-names></name><etal/></person-group>
<article-title>IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease</article-title>. <source>J Exp Med</source> (<year>2011</year>) <volume>208</volume>(<issue>6</issue>):<fpage>1127</fpage>&#8211;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20101712</pub-id><?supplied-pmid 21576383?><pub-id pub-id-type="pmid">21576383</pub-id></mixed-citation></ref><ref id="B173"><label>173</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteleone</surname><given-names>I</given-names></name><name><surname>Rizzo</surname><given-names>A</given-names></name><name><surname>Sarra</surname><given-names>M</given-names></name><name><surname>Sica</surname><given-names>G</given-names></name><name><surname>Sileri</surname><given-names>P</given-names></name><name><surname>Biancone</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract</article-title>. <source>Gastroenterology</source> (<year>2011</year>) <volume>141</volume>(<issue>1</issue>):<fpage>237</fpage>&#8211;<lpage>48, 248.e1</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2011.04.007</pub-id><?supplied-pmid 21600206?><pub-id pub-id-type="pmid">21600206</pub-id></mixed-citation></ref><ref id="B174"><label>174</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benson</surname><given-names>JM</given-names></name><name><surname>Shepherd</surname><given-names>DM</given-names></name></person-group>. <article-title>Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn&#8217;s disease</article-title>. <source>Toxicol Sci</source> (<year>2011</year>) <volume>120</volume>(<issue>1</issue>):<fpage>68</fpage>&#8211;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1093/toxsci/kfq360</pub-id><?supplied-pmid 21131560?><pub-id pub-id-type="pmid">21131560</pub-id></mixed-citation></ref><ref id="B175"><label>175</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heller</surname><given-names>F</given-names></name><name><surname>Fuss</surname><given-names>IJ</given-names></name><name><surname>Nieuwenhuis</surname><given-names>EE</given-names></name><name><surname>Blumberg</surname><given-names>RS</given-names></name><name><surname>Strober</surname><given-names>W</given-names></name></person-group>
<article-title>Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells</article-title>. <source>Immunity</source> (<year>2002</year>) <volume>17</volume>(<issue>5</issue>):<fpage>629</fpage>&#8211;<lpage>38</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(02)00453-3</pub-id><pub-id pub-id-type="pmid">12433369</pub-id></mixed-citation></ref><ref id="B176"><label>176</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>YC</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Shao</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>XL</given-names></name><name><surname>Chen</surname><given-names>JN</given-names></name><etal/></person-group>
<article-title>3,3 &#8217;-Diindolylmethane alleviates oxazolone-induced colitis through Th2/Th17 suppression and Treg induction</article-title>. <source>Mol Immunol</source> (<year>2013</year>) <volume>53</volume>(<issue>4</issue>):<fpage>335</fpage>&#8211;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1016/j.molimm.2012.09.007</pub-id><?supplied-pmid 23085552?><pub-id pub-id-type="pmid">23085552</pub-id></mixed-citation></ref><ref id="B177"><label>177</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neurath</surname><given-names>MF</given-names></name></person-group>. <article-title>Cytokines in inflammatory bowel disease</article-title>. <source>Nat Rev Immunol</source> (<year>2014</year>) <volume>14</volume>(<issue>5</issue>):<fpage>329</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1038/nri3661</pub-id><?supplied-pmid 24751956?><pub-id pub-id-type="pmid">24751956</pub-id></mixed-citation></ref><ref id="B178"><label>178</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sedhom</surname><given-names>MAK</given-names></name><name><surname>Pichery</surname><given-names>M</given-names></name><name><surname>Murdoch</surname><given-names>JR</given-names></name><name><surname>Foligne</surname><given-names>B</given-names></name><name><surname>Ortega</surname><given-names>N</given-names></name><name><surname>Normand</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice</article-title>. <source>Gut</source> (<year>2013</year>) <volume>62</volume>(<issue>12</issue>):<fpage>1714</fpage>&#8211;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1136/gutjnl-2011-301785</pub-id><?supplied-pmid 23172891?><pub-id pub-id-type="pmid">23172891</pub-id></mixed-citation></ref><ref id="B179"><label>179</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastorelli</surname><given-names>L</given-names></name><name><surname>Garg</surname><given-names>RR</given-names></name><name><surname>Hoang</surname><given-names>SB</given-names></name><name><surname>Spina</surname><given-names>L</given-names></name><name><surname>Mattioli</surname><given-names>B</given-names></name><name><surname>Scarpa</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>(<issue>17</issue>):<fpage>8017</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0912678107</pub-id><?supplied-pmid 20385815?><pub-id pub-id-type="pmid">20385815</pub-id></mixed-citation></ref><ref id="B180"><label>180</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zenewicz</surname><given-names>LA</given-names></name><name><surname>Flavell</surname><given-names>RA</given-names></name></person-group>. <article-title>Recent advances in IL-22 biology</article-title>. <source>Int Immunol</source> (<year>2011</year>) <volume>23</volume>(<issue>3</issue>):<fpage>159</fpage>&#8211;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1093/intimm/dxr001</pub-id><?supplied-pmid 21393631?><pub-id pub-id-type="pmid">21393631</pub-id></mixed-citation></ref><ref id="B181"><label>181</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahy</surname><given-names>JV</given-names></name></person-group>
<article-title>Type 2 inflammation in asthma &#8211; present in most, absent in many (vol 15, pg 57, 2015)</article-title>. <source>Nat Rev Immunol</source> (<year>2015</year>) <volume>15</volume>(<issue>2</issue>):<fpage>130</fpage><pub-id pub-id-type="doi">10.1038/nri3807</pub-id></mixed-citation></ref><ref id="B182"><label>182</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenzie</surname><given-names>AN</given-names></name></person-group>. <article-title>Type-2 innate lymphoid cells in asthma and allergy</article-title>. <source>Ann Am Thorac Soc</source> (<year>2014</year>) <volume>11</volume>(<issue>Suppl 5</issue>):<fpage>S263</fpage>&#8211;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1513/AnnalsATS.201403-097AW</pub-id><?supplied-pmid 25525730?><pub-id pub-id-type="pmid">25525730</pub-id></mixed-citation></ref><ref id="B183"><label>183</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SG</given-names></name><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Kjarsgaard</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Oliveria</surname><given-names>JP</given-names></name><name><surname>O&#8217;Byrne</surname><given-names>PM</given-names></name><etal/></person-group>
<article-title>Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia</article-title>. <source>J Allergy Clin Immunol</source> (<year>2016</year>) <volume>137</volume>(<issue>1</issue>):<fpage>75</fpage>&#8211;<lpage>86.e8</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaci.2015.05.037</pub-id><?supplied-pmid 26194544?><pub-id pub-id-type="pmid">26194544</pub-id></mixed-citation></ref><ref id="B184"><label>184</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>XM</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>XJ</given-names></name></person-group>. <article-title>TCDD-induced activation of aryl hydrocarbon receptor inhibits Th17 polarization and regulates non-eosinophilic airway inflammation in asthma</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>(<issue>3</issue>):<fpage>e0150551</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0150551</pub-id><?supplied-pmid 26938767?><pub-id pub-id-type="pmid">26938767</pub-id></mixed-citation></ref><ref id="B185"><label>185</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thatcher</surname><given-names>TH</given-names></name><name><surname>Williams</surname><given-names>MA</given-names></name><name><surname>Pollock</surname><given-names>SJ</given-names></name><name><surname>McCarthy</surname><given-names>CE</given-names></name><name><surname>Lacy</surname><given-names>SH</given-names></name><name><surname>Phipps</surname><given-names>RP</given-names></name><etal/></person-group>
<article-title>Endogenous ligands of the aryl hydrocarbon receptor regulate lung dendritic cell function</article-title>. <source>Immunology</source> (<year>2016</year>) <volume>147</volume>(<issue>1</issue>):<fpage>41</fpage>&#8211;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1111/imm.12540</pub-id><?supplied-pmid 26555456?><pub-id pub-id-type="pmid">26555456</pub-id></mixed-citation></ref><ref id="B186"><label>186</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luebke</surname><given-names>RW</given-names></name><name><surname>Copeland</surname><given-names>CB</given-names></name><name><surname>Daniels</surname><given-names>M</given-names></name><name><surname>Lambert</surname><given-names>AL</given-names></name><name><surname>Gilmour</surname><given-names>MI</given-names></name></person-group>. <article-title>Suppression of allergic immune responses to house dust mite (HDM) in rats exposed to 2,3,7,8-TCDD</article-title>. <source>Toxicol Sci</source> (<year>2001</year>) <volume>62</volume>(<issue>1</issue>):<fpage>71</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1093/toxsci/62.1.71</pub-id><?supplied-pmid 11399795?><pub-id pub-id-type="pmid">11399795</pub-id></mixed-citation></ref><ref id="B187"><label>187</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YH</given-names></name><name><surname>Wills-Karp</surname><given-names>M</given-names></name></person-group>. <article-title>The potential role of interleukin-17 in severe asthma</article-title>. <source>Curr Allergy Asthma Rep</source> (<year>2011</year>) <volume>11</volume>(<issue>5</issue>):<fpage>388</fpage>&#8211;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1007/s11882-011-0210-y</pub-id><?supplied-pmid 21773747?><pub-id pub-id-type="pmid">21773747</pub-id></mixed-citation></ref><ref id="B188"><label>188</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>IA</given-names></name><name><surname>Patterson</surname><given-names>AD</given-names></name><name><surname>Perdew</surname><given-names>GH</given-names></name></person-group>. <article-title>Aryl hydrocarbon receptor ligands in cancer: friend and foe</article-title>. <source>Nat Rev Cancer</source> (<year>2014</year>) <volume>14</volume>(<issue>12</issue>):<fpage>801</fpage>&#8211;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1038/nrc3846</pub-id><?supplied-pmid 25568920?><pub-id pub-id-type="pmid">25568920</pub-id></mixed-citation></ref><ref id="B189"><label>189</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Triantafillidis</surname><given-names>JK</given-names></name><name><surname>Nasioulas</surname><given-names>G</given-names></name><name><surname>Kosmidis</surname><given-names>PA</given-names></name></person-group>
<article-title>Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies</article-title>. <source>Anticancer Res</source> (<year>2009</year>) <volume>29</volume>(<issue>7</issue>):<fpage>2727</fpage>&#8211;<lpage>37</lpage>.<pub-id pub-id-type="pmid">19596953</pub-id></mixed-citation></ref><ref id="B190"><label>190</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchberger</surname><given-names>S</given-names></name><name><surname>Royston</surname><given-names>DJ</given-names></name><name><surname>Boulard</surname><given-names>O</given-names></name><name><surname>Thornton</surname><given-names>E</given-names></name><name><surname>Franchini</surname><given-names>F</given-names></name><name><surname>Szabady</surname><given-names>RL</given-names></name><etal/></person-group>
<article-title>Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>(<issue>5</issue>):<fpage>917</fpage>&#8211;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20122308</pub-id><?supplied-pmid 23589566?><pub-id pub-id-type="pmid">23589566</pub-id></mixed-citation></ref></ref-list></back></article>